ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||||||||||||||||||||
perfluorooctanoic acid
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | A2M | alpha-2-macroglobulin |
|
affects expression | ISO | 12 | 9,220,304 | 9,268,558 | RGD:6480464 | CTD | |
| G | ABAT | 4-aminobutyrate aminotransferase |
|
decreases expression | ISO | 16 | 8,768,444 | 8,878,432 | RGD:6480464 | CTD | |
| G | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
|
increases expression | ISO | 9 | 107,543,283 | 107,690,527 | RGD:6480464 | CTD | |
| G | ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 |
|
decreases expression | ISO | 16 | 2,325,879 | 2,390,747 | RGD:6480464 | CTD | |
| G | ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 |
|
affects expression | ISO | 16 | 2,325,879 | 2,390,747 | RGD:6480464 | CTD | |
| G | ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
|
decreases expression | ISO | 7 | 87,031,361 | 87,105,019 | RGD:6480464 | CTD | |
| G | ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
increases expression | ISO | 10 | 101,542,463 | 101,611,662 | RGD:6480464 | CTD | |
| G | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
increases expression | ISO | 17 | 48,712,218 | 48,769,063 | RGD:6480464 | CTD | |
| G | ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
affects expression | ISO | 17 | 48,712,218 | 48,769,063 | RGD:6480464 | CTD | |
| G | ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
|
decreases expression | ISO | 16 | 16,243,422 | 16,317,328 | RGD:6480464 | CTD | |
| G | ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 |
|
affects expression | ISO | 1 | 94,883,933 | 94,984,219 | RGD:6480464 | CTD | |
| G | ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 |
|
increases expression | ISO | 1 | 94,883,933 | 94,984,219 | RGD:6480464 | CTD | |
| G | ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 |
|
increases expression | ISO | 1 | 94,883,933 | 94,984,219 | RGD:6480464 | CTD | |
| G | ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
|
increases expression | ISO | 21 | 43,619,799 | 43,717,354 | RGD:6480464 | CTD | |
| G | ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 |
|
decreases expression | ISO | 2 | 44,039,611 | 44,065,958 | RGD:6480464 | CTD | |
| G | ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 |
|
decreases expression | ISO | 2 | 44,066,103 | 44,105,605 | RGD:6480464 | CTD | |
| G | ABP1 | amiloride binding protein 1 (amine oxidase (copper-containing)) |
|
multiple interactions | ISO | 7 | 150,549,573 | 150,558,379 | RGD:6480464 | CTD | |
| G | ABTB2 | ankyrin repeat and BTB (POZ) domain containing 2 |
|
decreases expression | ISO | 11 | 34,172,534 | 34,379,555 | RGD:6480464 | CTD | |
| G | ACAA1 | acetyl-CoA acyltransferase 1 |
|
affects expression | ISO | 3 | 38,164,201 | 38,178,733 | RGD:6480464 | CTD | |
| G | ACAA1 | acetyl-CoA acyltransferase 1 |
|
increases expression | ISO | 3 | 38,164,201 | 38,178,733 | RGD:6480464 | CTD | |
| G | ACAA1 | acetyl-CoA acyltransferase 1 |
|
multiple interactions | ISO | 3 | 38,164,201 | 38,178,733 | RGD:6480464 | CTD | |
| G | ACAA1 | acetyl-CoA acyltransferase 1 |
|
increases expression | ISO | 3 | 38,164,201 | 38,178,733 | RGD:6480464 | CTD | |
| G | ACAA1 | acetyl-CoA acyltransferase 1 |
|
increases expression | ISO | 3 | 38,164,201 | 38,178,733 | RGD:6480464 | CTD | |
| G | ACAA2 | acetyl-CoA acyltransferase 2 |
|
affects expression | ISO | 18 | 47,309,874 | 47,340,251 | RGD:6480464 | CTD | |
| G | ACAA2 | acetyl-CoA acyltransferase 2 |
|
increases expression | ISO | 18 | 47,309,874 | 47,340,251 | RGD:6480464 | CTD | |
| G | ACACA | acetyl-CoA carboxylase alpha |
|
increases expression | ISO | 17 | 35,441,927 | 35,766,902 | RGD:6480464 | CTD | |
| G | ACACB | acetyl-CoA carboxylase beta |
|
increases expression | ISO | 12 | 109,577,202 | 109,706,031 | RGD:6480464 | CTD | |
| G | ACAD10 | acyl-CoA dehydrogenase family, member 10 |
|
increases expression | ISO | 12 | 112,123,857 | 112,194,911 | RGD:6480464 | CTD | |
| G | ACAD10 | acyl-CoA dehydrogenase family, member 10 |
|
multiple interactions | ISO | 12 | 112,123,857 | 112,194,911 | RGD:6480464 | CTD | |
| G | ACAD11 | acyl-CoA dehydrogenase family, member 11 |
|
affects expression | ISO | 3 | 132,276,982 | 132,378,975 | RGD:6480464 | CTD | |
| G | ACAD11 | acyl-CoA dehydrogenase family, member 11 |
|
increases expression | ISO | 3 | 132,276,982 | 132,378,975 | RGD:6480464 | CTD | |
| G | ACAD11 | acyl-CoA dehydrogenase family, member 11 |
|
multiple interactions | ISO | 3 | 132,276,982 | 132,378,975 | RGD:6480464 | CTD | |
| G | ACADL | acyl-CoA dehydrogenase, long chain |
|
affects expression | ISO | 2 | 211,052,714 | 211,090,215 | RGD:6480464 | CTD | |
| G | ACADL | acyl-CoA dehydrogenase, long chain |
|
increases expression | ISO | 2 | 211,052,714 | 211,090,215 | RGD:6480464 | CTD | |
| G | ACADL | acyl-CoA dehydrogenase, long chain |
|
increases expression | ISO | 2 | 211,052,714 | 211,090,215 | RGD:6480464 | CTD | |
| G | ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
increases expression | ISO | 1 | 76,190,043 | 76,229,355 | RGD:6480464 | CTD | |
| G | ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
affects expression | ISO | 1 | 76,190,043 | 76,229,355 | RGD:6480464 | CTD | |
| G | ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
increases expression | ISO | 1 | 76,190,043 | 76,229,355 | RGD:6480464 | CTD | |
| G | ACADS | acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
affects expression | ISO | 12 | 121,163,571 | 121,177,811 | RGD:6480464 | CTD | |
| G | ACADSB | acyl-CoA dehydrogenase, short/branched chain |
|
decreases expression | ISO | 10 | 124,768,429 | 124,817,806 | RGD:6480464 | CTD | |
| G | ACADSB | acyl-CoA dehydrogenase, short/branched chain |
|
multiple interactions | ISO | 10 | 124,768,429 | 124,817,806 | RGD:6480464 | CTD | |
| G | ACADVL | acyl-CoA dehydrogenase, very long chain |
|
increases expression | ISO | 17 | 7,120,444 | 7,128,586 | RGD:6480464 | CTD | |
| G | ACADVL | acyl-CoA dehydrogenase, very long chain |
|
multiple interactions | ISO | 17 | 7,120,444 | 7,128,586 | RGD:6480464 | CTD | |
| G | ACADVL | acyl-CoA dehydrogenase, very long chain |
|
increases expression | ISO | 17 | 7,120,444 | 7,128,586 | RGD:6480464 | CTD | |
| G | ACAT1 | acetyl-CoA acetyltransferase 1 |
|
increases expression | ISO | 11 | 107,992,258 | 108,018,895 | RGD:6480464 | CTD | |
| G | ACAT2 | acetyl-CoA acetyltransferase 2 |
|
increases expression | ISO | 6 | 160,182,989 | 160,200,087 | RGD:6480464 | CTD | |
| G | ACAT2 | acetyl-CoA acetyltransferase 2 |
|
multiple interactions | ISO | 6 | 160,182,989 | 160,200,087 | RGD:6480464 | CTD | |
| G | ACBD3 | acyl-CoA binding domain containing 3 |
|
affects expression | ISO | 1 | 226,332,380 | 226,374,423 | RGD:6480464 | CTD | |
| G | ACLY | ATP citrate lyase |
|
decreases expression | ISO | 17 | 40,023,179 | 40,075,272 | RGD:6480464 | CTD | |
| G | ACO1 | aconitase 1, soluble |
|
increases expression | ISO | 9 | 32,384,601 | 32,450,834 | RGD:6480464 | CTD | |
| G | ACO2 | aconitase 2, mitochondrial |
|
increases expression | ISO | 22 | 41,865,129 | 41,924,993 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
affects expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
increases expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
increases expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
affects expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOT12 | acyl-CoA thioesterase 12 |
|
increases expression | ISO | 5 | 80,625,947 | 80,689,988 | RGD:6480464 | CTD | |
| G | ACOT2 | acyl-CoA thioesterase 2 |
|
affects expression | ISO | 14 | 74,034,324 | 74,042,362 | RGD:6480464 | CTD | |
| G | ACOT2 | acyl-CoA thioesterase 2 |
|
increases expression | ISO | 14 | 74,034,324 | 74,042,362 | RGD:6480464 | CTD | |
| G | ACOT2 | acyl-CoA thioesterase 2 |
|
increases expression | ISO | 14 | 74,034,324 | 74,042,362 | RGD:6480464 | CTD | |
| G | ACOT4 | acyl-CoA thioesterase 4 |
|
increases expression | ISO | 14 | 74,058,410 | 74,062,470 | RGD:6480464 | CTD | |
| G | ACOT7 | acyl-CoA thioesterase 7 |
|
increases expression | ISO | 1 | 6,324,332 | 6,453,826 | RGD:6480464 | CTD | |
| G | ACOT8 | acyl-CoA thioesterase 8 |
|
increases expression | ISO | 20 | 44,470,360 | 44,486,048 | RGD:6480464 | CTD | |
| G | ACOT8 | acyl-CoA thioesterase 8 |
|
increases expression | ISO | 20 | 44,470,360 | 44,486,048 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
affects expression | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
increases expression | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
multiple interactions | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
increases activity | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
increases expression | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX2 | acyl-CoA oxidase 2, branched chain |
|
decreases expression | ISO | 3 | 58,490,863 | 58,522,929 | RGD:6480464 | CTD | |
| G | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
|
affects expression | ISO | 4 | 185,676,749 | 185,747,215 | RGD:6480464 | CTD | |
| G | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions | ISO | 4 | 185,676,749 | 185,747,215 | RGD:6480464 | CTD | |
| G | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
|
increases expression | ISO | 4 | 185,676,749 | 185,747,215 | RGD:6480464 | CTD | |
| G | ACSL3 | acyl-CoA synthetase long-chain family member 3 |
|
affects expression | ISO | 2 | 223,725,732 | 223,808,119 | RGD:6480464 | CTD | |
| G | ACSL3 | acyl-CoA synthetase long-chain family member 3 |
|
increases expression | ISO | 2 | 223,725,732 | 223,808,119 | RGD:6480464 | CTD | |
| G | ACSL3 | acyl-CoA synthetase long-chain family member 3 |
|
increases expression | ISO | 2 | 223,725,732 | 223,808,119 | RGD:6480464 | CTD | |
| G | ACSL4 | acyl-CoA synthetase long-chain family member 4 |
|
affects expression | ISO | X | 108,884,564 | 108,976,621 | RGD:6480464 | CTD | |
| G | ACSL4 | acyl-CoA synthetase long-chain family member 4 |
|
multiple interactions | ISO | X | 108,884,564 | 108,976,621 | RGD:6480464 | CTD | |
| G | ACSL4 | acyl-CoA synthetase long-chain family member 4 |
|
increases expression | ISO | X | 108,884,564 | 108,976,621 | RGD:6480464 | CTD | |
| G | ACSL5 | acyl-CoA synthetase long-chain family member 5 |
|
increases expression | ISO | 10 | 114,133,916 | 114,188,138 | RGD:6480464 | CTD | |
| G | ACSL5 | acyl-CoA synthetase long-chain family member 5 |
|
affects expression | ISO | 10 | 114,133,916 | 114,188,138 | RGD:6480464 | CTD | |
| G | ACSL5 | acyl-CoA synthetase long-chain family member 5 |
|
multiple interactions | ISO | 10 | 114,133,916 | 114,188,138 | RGD:6480464 | CTD | |
| G | ACSL5 | acyl-CoA synthetase long-chain family member 5 |
|
decreases expression | ISO | 10 | 114,133,916 | 114,188,138 | RGD:6480464 | CTD | |
| G | ACSM1 | acyl-CoA synthetase medium-chain family member 1 |
|
decreases expression | ISO | 16 | 20,634,559 | 20,702,578 | RGD:6480464 | CTD | |
| G | ADAM17 | ADAM metallopeptidase domain 17 |
|
decreases expression | ISO | 2 | 9,629,392 | 9,695,917 | RGD:6480464 | CTD | |
| G | ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
|
affects expression | ISO | 5 | 33,527,286 | 33,892,124 | RGD:6480464 | CTD | |
| G | ADARB1 | adenosine deaminase, RNA-specific, B1 |
|
increases expression | ISO | 21 | 46,494,493 | 46,646,478 | RGD:6480464 | CTD | |
| G | ADCY10 | adenylate cyclase 10 (soluble) |
|
increases expression | ISO | 1 | 167,778,625 | 167,883,453 | RGD:6480464 | CTD | |
| G | ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide |
|
affects expression | ISO | 4 | 100,257,649 | 100,273,917 | RGD:6480464 | CTD | |
| G | ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide |
|
decreases expression | ISO | 4 | 100,044,832 | 100,065,449 | RGD:6480464 | CTD | |
| G | ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide |
|
multiple interactions | ISO | 4 | 100,044,832 | 100,065,449 | RGD:6480464 | CTD | |
| G | ADH7 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
affects expression | ISO | 4 | 100,333,418 | 100,356,667 | RGD:6480464 | CTD | |
| G | ADH7 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
decreases expression | ISO | 4 | 100,333,418 | 100,356,667 | RGD:6480464 | CTD | |
| G | ADH7 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
multiple interactions | ISO | 4 | 100,333,418 | 100,356,667 | RGD:6480464 | CTD | |
| G | ADHFE1 | alcohol dehydrogenase, iron containing, 1 |
|
affects expression | ISO | 8 | 67,344,718 | 67,381,044 | RGD:6480464 | CTD | |
| G | ADIPOR1 | adiponectin receptor 1 |
|
increases expression | ISO | 1 | 202,909,960 | 202,927,700 | RGD:6480464 | CTD | |
| G | ADIPOR2 | adiponectin receptor 2 |
|
increases expression | ISO | 12 | 1,800,247 | 1,897,845 | RGD:6480464 | CTD | |
| G | ADIPOR2 | adiponectin receptor 2 |
|
decreases expression | ISO | 12 | 1,800,247 | 1,897,845 | RGD:6480464 | CTD | |
| G | ADORA1 | adenosine A1 receptor |
|
affects expression | ISO | 1 | 203,096,836 | 203,136,533 | RGD:6480464 | CTD | |
| G | ADRA1B | adrenoceptor alpha 1B |
|
decreases expression | ISO | 5 | 159,343,740 | 159,400,017 | RGD:6480464 | CTD | |
| G | ADRB2 | adrenoceptor beta 2, surface |
|
increases expression | ISO | 5 | 148,206,156 | 148,208,197 | RGD:6480464 | CTD | |
| G | AES | amino-terminal enhancer of split |
|
decreases expression | ISO | 19 | 3,052,908 | 3,062,964 | RGD:6480464 | CTD | |
| G | AFM | afamin |
|
decreases expression | ISO | 4 | 74,347,462 | 74,369,718 | RGD:6480464 | CTD | |
| G | AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 |
|
affects expression | ISO | 9 | 139,567,595 | 139,581,911 | RGD:6480464 | CTD | |
| G | AGRN | agrin |
|
decreases expression | ISO | 1 | 955,503 | 991,499 | RGD:6480464 | CTD | |
| G | AGTR1 | angiotensin II receptor, type 1 |
|
decreases expression | ISO | 3 | 148,415,658 | 148,460,790 | RGD:6480464 | CTD | |
| G | AHNAK | AHNAK nucleoprotein |
|
increases expression | ISO | 11 | 62,201,016 | 62,314,332 | RGD:6480464 | CTD | |
| G | AHR | aryl hydrocarbon receptor |
|
multiple interactions | ISO | 7 | 17,338,276 | 17,385,775 | RGD:6480464 | CTD | |
| G | AHR | aryl hydrocarbon receptor |
|
decreases expression | ISO | 7 | 17,338,276 | 17,385,775 | RGD:6480464 | CTD | |
| G | AHSG | alpha-2-HS-glycoprotein |
|
decreases expression | ISO | 3 | 186,330,850 | 186,339,107 | RGD:6480464 | CTD | |
| G | AIMP2 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 |
|
increases expression | ISO | 7 | 6,048,882 | 6,063,465 | RGD:6480464 | CTD | |
| G | AK4 | adenylate kinase 4 |
|
decreases expression | ISO | 1 | 65,613,232 | 65,697,828 | RGD:6480464 | CTD | |
| G | AKR1A1 | aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
affects expression | ISO | 1 | 46,016,455 | 46,035,723 | RGD:6480464 | CTD | |
| G | AKR1C1 | aldo-keto reductase family 1, member C1 |
|
affects expression | ISO | 10 | 5,005,454 | 5,020,158 | RGD:6480464 | CTD | |
| G | AKR1C2 | aldo-keto reductase family 1, member C2 |
|
decreases expression | ISO | 10 | 5,029,967 | 5,060,225 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
affects expression | ISO | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
decreases expression | ISO | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
increases expression | ISO | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | AKR1D1 | aldo-keto reductase family 1, member D1 |
|
decreases expression | ISO | 7 | 137,761,178 | 137,803,050 | RGD:6480464 | CTD | |
| G | AKR1D1 | aldo-keto reductase family 1, member D1 |
|
decreases expression | ISO | 7 | 137,761,178 | 137,803,050 | RGD:6480464 | CTD | |
| G | AKTIP | AKT interacting protein |
|
increases expression | ISO | 16 | 53,525,192 | 53,537,170 | RGD:6480464 | CTD | |
| G | ALAD | aminolevulinate dehydratase |
|
decreases expression | ISO | 9 | 116,148,592 | 116,163,618 | RGD:6480464 | CTD | |
| G | ALAS1 | aminolevulinate, delta-, synthase 1 |
|
increases expression | ISO | 3 | 52,232,099 | 52,248,343 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
affects folding | EXP | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
multiple interactions | EXP | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
affects binding | EXP | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
affects binding | ISO | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALCAM | activated leukocyte cell adhesion molecule |
|
decreases expression | ISO | 3 | 105,085,557 | 105,295,757 | RGD:6480464 | CTD | |
| G | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 |
|
increases expression | ISO | 9 | 75,515,578 | 75,568,233 | RGD:6480464 | CTD | |
| G | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 |
|
affects expression | ISO | 9 | 75,515,578 | 75,568,233 | RGD:6480464 | CTD | |
| G | ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 |
|
increases expression | ISO | 9 | 75,515,578 | 75,568,233 | RGD:6480464 | CTD | |
| G | ALDH1B1 | aldehyde dehydrogenase 1 family, member B1 |
|
affects expression | ISO | 9 | 38,392,661 | 38,398,662 | RGD:6480464 | CTD | |
| G | ALDH1B1 | aldehyde dehydrogenase 1 family, member B1 |
|
decreases expression | ISO | 9 | 38,392,661 | 38,398,662 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
affects expression | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
decreases expression | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
multiple interactions | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 |
|
decreases expression | ISO | 3 | 125,822,404 | 125,900,029 | RGD:6480464 | CTD | |
| G | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) |
|
decreases expression | ISO | 12 | 112,204,691 | 112,247,789 | RGD:6480464 | CTD | |
| G | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 |
|
affects expression | ISO | 17 | 19,552,064 | 19,580,908 | RGD:6480464 | CTD | |
| G | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 |
|
increases expression | ISO | 17 | 19,552,064 | 19,580,908 | RGD:6480464 | CTD | |
| G | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 |
|
increases expression | ISO | 17 | 19,552,064 | 19,580,908 | RGD:6480464 | CTD | |
| G | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 |
|
multiple interactions | ISO | 17 | 19,552,064 | 19,580,908 | RGD:6480464 | CTD | |
| G | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 |
|
affects expression | ISO | 1 | 165,631,449 | 165,667,900 | RGD:6480464 | CTD | |
| G | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 |
|
increases expression | ISO | 1 | 165,631,449 | 165,667,900 | RGD:6480464 | CTD | |
| G | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 |
|
multiple interactions | ISO | 1 | 165,631,449 | 165,667,900 | RGD:6480464 | CTD | |
| G | ALDOA | aldolase A, fructose-bisphosphate |
|
increases expression | ISO | 16 | 30,064,411 | 30,081,741 | RGD:6480464 | CTD | |
| G | ALDOB | aldolase B, fructose-bisphosphate |
|
affects expression | ISO | 9 | 104,182,842 | 104,198,062 | RGD:6480464 | CTD | |
| G | ALG10B | ALG10B, alpha-1,2-glucosyltransferase |
|
increases expression | ISO | 12 | 38,710,557 | 38,723,528 | RGD:6480464 | CTD | |
| G | ALOX12 | arachidonate 12-lipoxygenase |
|
multiple interactions | ISO | 17 | 6,899,384 | 6,914,055 | RGD:6480464 | CTD | |
| G | ALPL | alkaline phosphatase, liver/bone/kidney |
|
increases expression | ISO | 1 | 21,835,858 | 21,904,905 | RGD:6480464 | CTD | |
| G | AMD1 | adenosylmethionine decarboxylase 1 |
|
increases expression | ISO | 6 | 111,195,987 | 111,216,913 | RGD:6480464 | CTD | |
| G | AMPH | amphiphysin |
|
affects expression | ISO | 7 | 38,423,297 | 38,671,167 | RGD:6480464 | CTD | |
| G | AMY1C | amylase, alpha 1C (salivary) |
|
decreases expression | ISO | 1 | 104,292,441 | 104,301,310 | RGD:6480464 | CTD | |
| G | AMY2A | amylase, alpha 2A (pancreatic) |
|
affects expression | ISO | 1 | 104,159,999 | 104,168,400 | RGD:6480464 | CTD | |
| G | ANGPTL4 | angiopoietin-like 4 |
|
affects expression | ISO | 19 | 8,429,011 | 8,439,257 | RGD:6480464 | CTD | |
| G | ANGPTL4 | angiopoietin-like 4 |
|
increases expression | ISO | 19 | 8,429,011 | 8,439,257 | RGD:6480464 | CTD | |
| G | ANXA1 | annexin A1 |
|
increases expression | ISO | 9 | 75,766,781 | 75,785,307 | RGD:6480464 | CTD | |
| G | ANXA3 | annexin A3 |
|
decreases expression | ISO | 4 | 79,472,742 | 79,531,605 | RGD:6480464 | CTD | |
| G | ANXA7 | annexin A7 |
|
increases expression | ISO | 10 | 75,135,189 | 75,173,841 | RGD:6480464 | CTD | |
| G | AOX1 | aldehyde oxidase 1 |
|
affects expression | ISO | 2 | 201,450,731 | 201,536,218 | RGD:6480464 | CTD | |
| G | APCS | amyloid P component, serum |
|
affects expression | ISO | 1 | 159,557,616 | 159,558,661 | RGD:6480464 | CTD | |
| G | APCS | amyloid P component, serum |
|
decreases expression | ISO | 1 | 159,557,616 | 159,558,661 | RGD:6480464 | CTD | |
| G | APCS | amyloid P component, serum |
|
multiple interactions | ISO | 1 | 159,557,616 | 159,558,661 | RGD:6480464 | CTD | |
| G | APCS | amyloid P component, serum |
|
decreases expression | ISO | 1 | 159,557,616 | 159,558,661 | RGD:6480464 | CTD | |
| G | APEH | N-acylaminoacyl-peptide hydrolase |
|
increases expression | ISO | 3 | 49,711,435 | 49,720,934 | RGD:6480464 | CTD | |
| G | APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression | ISO | 14 | 20,923,290 | 20,925,931 | RGD:6480464 | CTD | |
| G | APOA1 | apolipoprotein A-I |
|
decreases expression | ISO | 11 | 116,706,469 | 116,708,338 | RGD:6480464 | CTD | |
| G | APOA1 | apolipoprotein A-I |
|
decreases expression | ISO | 11 | 116,706,469 | 116,708,338 | RGD:6480464 | CTD | |
| G | APOA4 | apolipoprotein A-IV |
|
decreases expression | ISO | 11 | 116,691,418 | 116,694,011 | RGD:6480464 | CTD | |
| G | APOA5 | apolipoprotein A-V |
|
decreases expression | ISO | 11 | 116,660,086 | 116,663,136 | RGD:6480464 | CTD | |
| G | APOB | apolipoprotein B (including Ag(x) antigen) |
|
affects localization | ISO | 2 | 21,224,301 | 21,266,945 | RGD:6480464 | CTD | |
| G | APOBEC1 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
|
decreases expression | ISO | 12 | 7,801,996 | 7,818,502 | RGD:6480464 | CTD | |
| G | APOC3 | apolipoprotein C-III |
|
decreases expression | ISO | 11 | 116,700,624 | 116,703,787 | RGD:6480464 | CTD | |
| G | APOC3 | apolipoprotein C-III |
|
decreases expression | ISO | 11 | 116,700,624 | 116,703,787 | RGD:6480464 | CTD | |
| G | APOC4 | apolipoprotein C-IV |
|
affects expression | ISO | 19 | 45,445,495 | 45,448,753 | RGD:6480464 | CTD | |
| G | APOC4 | apolipoprotein C-IV |
|
decreases expression | ISO | 19 | 45,445,495 | 45,448,753 | RGD:6480464 | CTD | |
| G | APOC4 | apolipoprotein C-IV |
|
decreases expression | ISO | 19 | 45,445,495 | 45,448,753 | RGD:6480464 | CTD | |
| G | APOF | apolipoprotein F |
|
decreases expression | ISO | 12 | 56,754,355 | 56,756,583 | RGD:6480464 | CTD | |
| G | APOM | apolipoprotein M |
|
decreases expression | ISO | 6 | 31,620,187 | 31,625,987 | RGD:6480464 | CTD | |
| G | APP | amyloid beta (A4) precursor protein |
|
increases expression | ISO | 21 | 27,252,861 | 27,543,446 | RGD:6480464 | CTD | |
| G | AQP3 | aquaporin 3 (Gill blood group) |
|
increases expression | ISO | 9 | 33,441,152 | 33,447,631 | RGD:6480464 | CTD | |
| G | AQP3 | aquaporin 3 (Gill blood group) |
|
affects expression | ISO | 9 | 33,441,152 | 33,447,631 | RGD:6480464 | CTD | |
| G | AQP7 | aquaporin 7 |
|
increases expression | ISO | 9 | 33,384,948 | 33,402,517 | RGD:6480464 | CTD | |
| G | AQP8 | aquaporin 8 |
|
decreases expression | ISO | 16 | 25,228,285 | 25,240,253 | RGD:6480464 | CTD | |
| G | AQP9 | aquaporin 9 |
|
affects expression | ISO | 15 | 58,430,408 | 58,478,110 | RGD:6480464 | CTD | |
| G | AQP9 | aquaporin 9 |
|
decreases expression | ISO | 15 | 58,430,408 | 58,478,110 | RGD:6480464 | CTD | |
| G | AREG | amphiregulin |
|
increases expression | ISO | 4 | 75,310,853 | 75,320,726 | RGD:6480464 | CTD | |
| G | ARF6 | ADP-ribosylation factor 6 |
|
increases expression | ISO | 14 | 50,359,736 | 50,363,772 | RGD:6480464 | CTD | |
| G | ARHGAP25 | Rho GTPase activating protein 25 |
|
decreases expression | ISO | 2 | 68,961,913 | 69,053,965 | RGD:6480464 | CTD | |
| G | ARL4A | ADP-ribosylation factor-like 4A |
|
increases expression | ISO | 7 | 12,726,452 | 12,730,559 | RGD:6480464 | CTD | |
| G | ARMC6 | armadillo repeat containing 6 |
|
increases expression | ISO | 19 | 19,144,387 | 19,168,987 | RGD:6480464 | CTD | |
| G | ARNTL | aryl hydrocarbon receptor nuclear translocator-like |
|
decreases expression | ISO | 11 | 13,299,325 | 13,408,813 | RGD:6480464 | CTD | |
| G | ARSB | arylsulfatase B |
|
increases expression | ISO | 5 | 78,073,032 | 78,282,357 | RGD:6480464 | CTD | |
| G | ASB13 | ankyrin repeat and SOCS box containing 13 |
|
affects expression | ISO | 10 | 5,680,820 | 5,708,558 | RGD:6480464 | CTD | |
| G | ASL | argininosuccinate lyase |
|
increases expression | ISO | 7 | 65,540,776 | 65,558,330 | RGD:6480464 | CTD | |
| G | ASNS | asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression | ISO | 7 | 97,481,429 | 97,501,854 | RGD:6480464 | CTD | |
| G | ASNSD1 | asparagine synthetase domain containing 1 |
|
increases expression | ISO | 2 | 190,526,125 | 190,535,557 | RGD:6480464 | CTD | |
| G | ATF3 | activating transcription factor 3 |
|
increases expression | ISO | 1 | 212,738,676 | 212,794,119 | RGD:6480464 | CTD | |
| G | ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) |
|
affects expression | ISO | 22 | 39,916,569 | 39,918,691 | RGD:6480464 | CTD | |
| G | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression | ISO | 1 | 116,915,795 | 116,947,396 | RGD:6480464 | CTD | |
| G | ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression | ISO | 12 | 110,719,032 | 110,788,898 | RGD:6480464 | CTD | |
| G | ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 |
|
decreases expression | ISO | 3 | 10,365,707 | 10,547,268 | RGD:6480464 | CTD | |
| G | ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
|
increases expression | ISO | 14 | 67,804,581 | 67,826,720 | RGD:6480464 | CTD | |
| G | ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
|
decreases expression | ISO | 18 | 55,313,658 | 55,470,327 | RGD:6480464 | CTD | |
| G | ATRN | attractin |
|
decreases expression | ISO | 20 | 3,451,665 | 3,631,769 | RGD:6480464 | CTD | |
| G | AVPR1A | arginine vasopressin receptor 1A |
|
decreases expression | ISO | 12 | 63,536,539 | 63,546,590 | RGD:6480464 | CTD | |
| G | AXIN2 | axin 2 |
|
decreases expression | ISO | 17 | 63,524,681 | 63,557,740 | RGD:6480464 | CTD | |
| G | AZIN1 | antizyme inhibitor 1 |
|
increases expression | ISO | 8 | 103,838,536 | 103,876,397 | RGD:6480464 | CTD | |
| G | BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
decreases expression | ISO | 9 | 104,122,699 | 104,147,287 | RGD:6480464 | CTD | |
| G | BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
decreases expression | ISO | 9 | 104,122,699 | 104,147,287 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
increases expression | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BBS2 | Bardet-Biedl syndrome 2 |
|
increases expression | ISO | 16 | 56,518,259 | 56,554,008 | RGD:6480464 | CTD | |
| G | BCAR1 | breast cancer anti-estrogen resistance 1 |
|
decreases expression | ISO | 16 | 75,262,928 | 75,301,951 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
decreases expression | EXP | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2L13 | BCL2-like 13 (apoptosis facilitator) |
|
increases expression | ISO | 22 | 18,121,350 | 18,213,621 | RGD:6480464 | CTD | |
| G | BET1 | Bet1 golgi vesicular membrane trafficking protein |
|
affects expression | ISO | 7 | 93,621,000 | 93,633,690 | RGD:6480464 | CTD | |
| G | BHMT | betaine--homocysteine S-methyltransferase |
|
affects expression | ISO | 5 | 78,407,604 | 78,428,113 | RGD:6480464 | CTD | |
| G | BHMT | betaine--homocysteine S-methyltransferase |
|
decreases expression | ISO | 5 | 78,407,604 | 78,428,113 | RGD:6480464 | CTD | |
| G | BLVRB | biliverdin reductase B (flavin reductase (NADPH)) |
|
multiple interactions | ISO | 19 | 40,953,691 | 40,971,725 | RGD:6480464 | CTD | |
| G | BLVRB | biliverdin reductase B (flavin reductase (NADPH)) |
|
increases expression | ISO | 19 | 40,953,691 | 40,971,725 | RGD:6480464 | CTD | |
| G | BMF | Bcl2 modifying factor |
|
decreases expression | ISO | 15 | 40,380,091 | 40,401,075 | RGD:6480464 | CTD | |
| G | BTG3 | BTG family, member 3 |
|
increases expression | ISO | 21 | 18,965,968 | 18,985,268 | RGD:6480464 | CTD | |
| G | C1QBP | complement component 1, q subcomponent binding protein |
|
increases expression | ISO | 17 | 5,336,099 | 5,342,471 | RGD:6480464 | CTD | |
| G | C1R | complement component 1, r subcomponent |
|
decreases expression | ISO | 12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:6480464 | CTD | |
| G | C1R | complement component 1, r subcomponent |
|
multiple interactions | ISO | 12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:6480464 | CTD | |
| G | C1R | complement component 1, r subcomponent |
|
decreases expression | ISO | 12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:6480464 | CTD | |
| G | C1R | complement component 1, r subcomponent |
|
affects expression | ISO | 12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:6480464 | CTD | |
| G | C1S | complement component 1, s subcomponent |
|
affects expression | ISO | 12 | 7,167,980 | 7,178,336 | RGD:6480464 | CTD | |
| G | C1S | complement component 1, s subcomponent |
|
decreases expression | ISO | 12 | 7,167,980 | 7,178,336 | RGD:6480464 | CTD | |
| G | C1S | complement component 1, s subcomponent |
|
multiple interactions | ISO | 12 | 7,167,980 | 7,178,336 | RGD:6480464 | CTD | |
| G | C1S | complement component 1, s subcomponent |
|
decreases expression | ISO | 12 | 7,167,980 | 7,178,336 | RGD:6480464 | CTD | |
| G | C2 | complement component 2 |
|
decreases expression | ISO | 6 | 31,865,562 | 31,913,449 | RGD:6480464 | CTD | |
| G | C2 | complement component 2 |
|
affects expression | ISO | 6 | 31,865,562 | 31,913,449 | RGD:6480464 | CTD | |
| G | C2 | complement component 2 |
|
multiple interactions | ISO | 6 | 31,865,562 | 31,913,449 | RGD:6480464 | CTD | |
| G | C3 | complement component 3 |
|
affects expression | ISO | 19 | 6,677,846 | 6,720,662 | RGD:6480464 | CTD | |
| G | C4A | complement component 4A (Rodgers blood group) |
|
increases expression | ISO | 6 | 31,949,834 | 31,970,457 | RGD:6480464 | CTD | |
| G | C4B | complement component 4B (Chido blood group) |
|
decreases expression | ISO | 6 | 31,982,572 | 32,003,195 | RGD:6480464 | CTD | |
| G | C4B | complement component 4B (Chido blood group) |
|
affects expression | ISO | 6 | 31,982,572 | 32,003,195 | RGD:6480464 | CTD | |
| G | C4B | complement component 4B (Chido blood group) |
|
multiple interactions | ISO | 6 | 31,982,572 | 32,003,195 | RGD:6480464 | CTD | |
| G | C4BPA | complement component 4 binding protein, alpha |
|
affects expression | ISO | 1 | 207,277,607 | 207,318,317 | RGD:6480464 | CTD | |
| G | C4BPA | complement component 4 binding protein, alpha |
|
decreases expression | ISO | 1 | 207,277,607 | 207,318,317 | RGD:6480464 | CTD | |
| G | C4BPA | complement component 4 binding protein, alpha |
|
multiple interactions | ISO | 1 | 207,277,607 | 207,318,317 | RGD:6480464 | CTD | |
| G | C4BPA | complement component 4 binding protein, alpha |
|
decreases expression | ISO | 1 | 207,277,607 | 207,318,317 | RGD:6480464 | CTD | |
| G | C4BPB | complement component 4 binding protein, beta |
|
decreases expression | ISO | 1 | 207,262,212 | 207,273,338 | RGD:6480464 | CTD | |
| G | C6 | complement component 6 |
|
decreases expression | ISO | 5 | 41,142,336 | 41,261,540 | RGD:6480464 | CTD | |
| G | C6 | complement component 6 |
|
increases expression | ISO | 5 | 41,142,336 | 41,261,540 | RGD:6480464 | CTD | |
| G | C6 | complement component 6 |
|
multiple interactions | ISO | 5 | 41,142,336 | 41,261,540 | RGD:6480464 | CTD | |
| G | C8A | complement component 8, alpha polypeptide |
|
affects expression | ISO | 1 | 57,320,443 | 57,383,894 | RGD:6480464 | CTD | |
| G | C8A | complement component 8, alpha polypeptide |
|
decreases expression | ISO | 1 | 57,320,443 | 57,383,894 | RGD:6480464 | CTD | |
| G | C8A | complement component 8, alpha polypeptide |
|
multiple interactions | ISO | 1 | 57,320,443 | 57,383,894 | RGD:6480464 | CTD | |
| G | C8B | complement component 8, beta polypeptide |
|
affects expression | ISO | 1 | 57,394,883 | 57,431,688 | RGD:6480464 | CTD | |
| G | C8B | complement component 8, beta polypeptide |
|
decreases expression | ISO | 1 | 57,394,883 | 57,431,688 | RGD:6480464 | CTD | |
| G | C8B | complement component 8, beta polypeptide |
|
multiple interactions | ISO | 1 | 57,394,883 | 57,431,688 | RGD:6480464 | CTD | |
| G | C8B | complement component 8, beta polypeptide |
|
decreases expression | ISO | 1 | 57,394,883 | 57,431,688 | RGD:6480464 | CTD | |
| G | C8G | complement component 8, gamma polypeptide |
|
affects expression | ISO | 9 | 139,839,698 | 139,841,426 | RGD:6480464 | CTD | |
| G | C9 | complement component 9 |
|
decreases expression | ISO | 5 | 39,284,377 | 39,364,655 | RGD:6480464 | CTD | |
| G | C9 | complement component 9 |
|
decreases expression | ISO | 5 | 39,284,377 | 39,364,655 | RGD:6480464 | CTD | |
| G | C9 | complement component 9 |
|
multiple interactions | ISO | 5 | 39,284,377 | 39,364,655 | RGD:6480464 | CTD | |
| G | CA3 | carbonic anhydrase III, muscle specific |
|
decreases expression | ISO | 8 | 86,351,056 | 86,361,269 | RGD:6480464 | CTD | |
| G | CA3 | carbonic anhydrase III, muscle specific |
|
decreases expression | ISO | 8 | 86,351,056 | 86,361,269 | RGD:6480464 | CTD | |
| G | CACNA1D | calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
decreases expression | ISO | 3 | 53,529,031 | 53,846,492 | RGD:6480464 | CTD | |
| G | CADPS2 | Ca++-dependent secretion activator 2 |
|
decreases expression | ISO | 7 | 121,958,478 | 122,526,813 | RGD:6480464 | CTD | |
| G | CALR | calreticulin |
|
decreases expression | ISO | 19 | 13,049,414 | 13,055,304 | RGD:6480464 | CTD | |
| G | CASP12 | caspase 12 (gene/pseudogene) |
|
increases expression | ISO | 11 | 104,756,445 | 104,769,397 | RGD:6480464 | CTD | |
| G | CASP2 | caspase 2, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 7 | 142,985,308 | 143,004,789 | RGD:6480464 | CTD | |
| G | CASP4 | caspase 4, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 11 | 104,813,594 | 104,839,325 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases expression | EXP | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases activity | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
affects expression | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
affects activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
decreases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases activity | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CATSPER2 | cation channel, sperm associated 2 |
|
increases expression | ISO | 15 | 43,922,772 | 43,941,039 | RGD:6480464 | CTD | |
| G | CAV2 | caveolin 2 |
|
decreases expression | ISO | 7 | 116,139,655 | 116,148,595 | RGD:6480464 | CTD | |
| G | CBR1 | carbonyl reductase 1 |
|
increases expression | ISO | 21 | 37,442,285 | 37,445,462 | RGD:6480464 | CTD | |
| G | CBS | cystathionine-beta-synthase |
|
affects expression | ISO | 21 | 44,473,301 | 44,496,472 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
increases expression | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
increases expression | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
increases expression | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND1 | cyclin D1 |
|
multiple interactions | ISO | 11 | 69,455,873 | 69,469,242 | RGD:6480464 | CTD | |
| G | CCND3 | cyclin D3 |
|
decreases expression | ISO | 6 | 41,902,671 | 42,016,610 | RGD:6480464 | CTD | |
| G | CCT3 | chaperonin containing TCP1, subunit 3 (gamma) |
|
increases expression | ISO | 1 | 156,278,752 | 156,308,206 | RGD:6480464 | CTD | |
| G | CD14 | CD14 molecule |
|
decreases expression | ISO | 5 | 140,011,313 | 140,013,286 | RGD:6480464 | CTD | |
| G | CD1D | CD1d molecule |
|
decreases expression | ISO | 1 | 158,149,737 | 158,156,217 | RGD:6480464 | CTD | |
| G | CD36 | CD36 molecule (thrombospondin receptor) |
|
increases expression | ISO | 7 | 80,231,504 | 80,308,593 | RGD:6480464 | CTD | |
| G | CD46 | CD46 molecule, complement regulatory protein |
|
increases expression | ISO | 1 | 207,925,383 | 207,968,861 | RGD:6480464 | CTD | |
| G | CD48 | CD48 molecule |
|
decreases expression | ISO | 1 | 160,648,536 | 160,681,641 | RGD:6480464 | CTD | |
| G | CD53 | CD53 molecule |
|
decreases expression | ISO | 1 | 111,413,821 | 111,442,558 | RGD:6480464 | CTD | |
| G | CD59 | CD59 molecule, complement regulatory protein |
|
decreases expression | ISO | 11 | 33,724,556 | 33,758,025 | RGD:6480464 | CTD | |
| G | CD82 | CD82 molecule |
|
decreases expression | ISO | 11 | 44,587,141 | 44,641,339 | RGD:6480464 | CTD | |
| G | CDC20 | cell division cycle 20 |
|
increases expression | ISO | 1 | 43,824,626 | 43,828,874 | RGD:6480464 | CTD | |
| G | CDC20 | cell division cycle 20 |
|
multiple interactions | ISO | 1 | 43,824,626 | 43,828,874 | RGD:6480464 | CTD | |
| G | CDC34 | cell division cycle 34 |
|
increases expression | ISO | 19 | 531,733 | 542,087 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN3 | cyclin-dependent kinase inhibitor 3 |
|
increases expression | ISO | 14 | 54,863,673 | 54,886,936 | RGD:6480464 | CTD | |
| G | CDKN3 | cyclin-dependent kinase inhibitor 3 |
|
multiple interactions | ISO | 14 | 54,863,673 | 54,886,936 | RGD:6480464 | CTD | |
| G | CDO1 | cysteine dioxygenase, type I |
|
decreases expression | ISO | 5 | 115,140,430 | 115,152,405 | RGD:6480464 | CTD | |
| G | CDO1 | cysteine dioxygenase, type I |
|
affects expression | ISO | 5 | 115,140,430 | 115,152,405 | RGD:6480464 | CTD | |
| G | CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma |
|
increases expression | ISO | 19 | 33,864,575 | 33,873,592 | RGD:6480464 | CTD | |
| G | CELA2A | chymotrypsin-like elastase family, member 2A |
|
affects expression | ISO | 1 | 15,783,223 | 15,798,586 | RGD:6480464 | CTD | |
| G | CELF2 | CUGBP, Elav-like family member 2 |
|
affects expression | ISO | 10 | 11,047,259 | 11,378,674 | RGD:6480464 | CTD | |
| G | CEPT1 | choline/ethanolamine phosphotransferase 1 |
|
increases expression | ISO | 1 | 111,682,249 | 111,727,724 | RGD:6480464 | CTD | |
| G | CES1 | carboxylesterase 1 |
|
affects expression | ISO | 16 | 55,836,763 | 55,867,075 | RGD:6480464 | CTD | |
| G | CES2 | carboxylesterase 2 |
|
affects expression | ISO | 16 | 66,968,347 | 66,978,999 | RGD:6480464 | CTD | |
| G | CES2 | carboxylesterase 2 |
|
multiple interactions | ISO | 16 | 66,968,347 | 66,978,999 | RGD:6480464 | CTD | |
| G | CES2 | carboxylesterase 2 |
|
decreases expression | ISO | 16 | 66,968,347 | 66,978,999 | RGD:6480464 | CTD | |
| G | CES2 | carboxylesterase 2 |
|
increases expression | ISO | 16 | 66,968,347 | 66,978,999 | RGD:6480464 | CTD | |
| G | CES3 | carboxylesterase 3 |
|
affects expression | ISO | 16 | 66,995,132 | 67,009,052 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
affects expression | ISO | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
decreases expression | ISO | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
multiple interactions | ISO | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFB | complement factor B |
|
decreases expression | ISO | 6 | 31,913,721 | 31,919,861 | RGD:6480464 | CTD | |
| G | CFH | complement factor H |
|
affects expression | ISO | 1 | 196,621,008 | 196,716,634 | RGD:6480464 | CTD | |
| G | CFH | complement factor H |
|
decreases expression | ISO | 1 | 196,621,008 | 196,716,634 | RGD:6480464 | CTD | |
| G | CFH | complement factor H |
|
multiple interactions | ISO | 1 | 196,621,008 | 196,716,634 | RGD:6480464 | CTD | |
| G | CFI | complement factor I |
|
affects expression | ISO | 4 | 110,661,848 | 110,723,335 | RGD:6480464 | CTD | |
| G | CFI | complement factor I |
|
decreases expression | ISO | 4 | 110,661,848 | 110,723,335 | RGD:6480464 | CTD | |
| G | CFI | complement factor I |
|
multiple interactions | ISO | 4 | 110,661,848 | 110,723,335 | RGD:6480464 | CTD | |
| G | CHCHD6 | coiled-coil-helix-coiled-coil-helix domain containing 6 |
|
increases expression | ISO | 3 | 126,423,063 | 126,679,263 | RGD:6480464 | CTD | |
| G | CHKB | choline kinase beta |
|
increases expression | ISO | 22 | 51,017,387 | 51,021,428 | RGD:6480464 | CTD | |
| G | CHORDC1 | cysteine and histidine-rich domain (CHORD) containing 1 |
|
increases expression | ISO | 11 | 89,933,597 | 89,956,532 | RGD:6480464 | CTD | |
| G | CHPT1 | choline phosphotransferase 1 |
|
affects expression | ISO | 12 | 102,091,417 | 102,122,846 | RGD:6480464 | CTD | |
| G | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
|
increases expression | ISO | 8 | 27,317,278 | 27,336,813 | RGD:6480464 | CTD | |
| G | CIDEA | cell death-inducing DFFA-like effector a |
|
increases expression | ISO | 18 | 12,254,318 | 12,277,594 | RGD:6480464 | CTD | |
| G | CIRBP | cold inducible RNA binding protein |
|
increases expression | ISO | 19 | 1,269,267 | 1,274,809 | RGD:6480464 | CTD | |
| G | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
decreases expression | ISO | 6 | 139,693,392 | 139,695,787 | RGD:6480464 | CTD | |
| G | CLCN3 | chloride channel, voltage-sensitive 3 |
|
increases expression | ISO | 4 | 170,541,672 | 170,644,338 | RGD:6480464 | CTD | |
| G | CLDN18 | claudin 18 |
|
affects expression | ISO | 3 | 137,717,658 | 137,752,494 | RGD:6480464 | CTD | |
| G | CLDN2 | claudin 2 |
|
affects expression | ISO | X | 106,143,394 | 106,174,091 | RGD:6480464 | CTD | |
| G | CLEC4F | C-type lectin domain family 4, member F |
|
decreases expression | ISO | 2 | 71,035,775 | 71,047,732 | RGD:6480464 | CTD | |
| G | CMTM6 | CKLF-like MARVEL transmembrane domain containing 6 |
|
decreases expression | ISO | 3 | 32,522,804 | 32,544,403 | RGD:6480464 | CTD | |
| G | CNKSR3 | CNKSR family member 3 |
|
increases expression | ISO | 6 | 154,726,433 | 154,831,753 | RGD:6480464 | CTD | |
| G | COL3A1 | collagen, type III, alpha 1 |
|
decreases expression | ISO | 2 | 189,839,099 | 189,877,472 | RGD:6480464 | CTD | |
| G | COL5A1 | collagen, type V, alpha 1 |
|
decreases expression | ISO | 9 | 137,533,652 | 137,736,689 | RGD:6480464 | CTD | |
| G | COLQ | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
|
increases expression | ISO | 3 | 15,491,640 | 15,563,258 | RGD:6480464 | CTD | |
| G | COMT | catechol-O-methyltransferase |
|
decreases expression | ISO | 22 | 19,929,263 | 19,957,498 | RGD:6480464 | CTD | |
| G | CYP17A1 | cytochrome P450, family 17, subfamily A, polypeptide 1 |
|
increases expression | ISO | 10 | 104,590,288 | 104,597,290 | RGD:6480464 | CTD | |
| G | CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 51,500,254 | 51,630,795 | RGD:6480464 | CTD | |
| G | CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
increases activity | ISO | 15 | 51,500,254 | 51,630,795 | RGD:6480464 | CTD | |
| G | CYP19A1 | cytochrome P450, family 19, subfamily A, polypeptide 1 |
|
decreases activity | ISO | 15 | 51,500,254 | 51,630,795 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
decreases expression | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions | ISO | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects expression | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases expression | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases expression | ISO | 15 | 75,041,184 | 75,048,941 | RGD:6480464 | CTD | |
| G | CYP27A1 | cytochrome P450, family 27, subfamily A, polypeptide 1 |
|
decreases expression | ISO | 2 | 219,646,472 | 219,680,016 | RGD:6480464 | CTD | |
| G | CYP27B1 | cytochrome P450, family 27, subfamily B, polypeptide 1 |
|
multiple interactions | ISO | 12 | 58,156,117 | 58,160,976 | RGD:6480464 | CTD | |
| G | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
increases expression | ISO | 19 | 41,594,356 | 41,602,100 | RGD:6480464 | CTD | |
| G | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions | ISO | 19 | 41,594,356 | 41,602,100 | RGD:6480464 | CTD | |
| G | CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases expression | ISO | 19 | 41,349,443 | 41,356,352 | RGD:6480464 | CTD | |
| G | CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions | ISO | 19 | 41,349,443 | 41,356,352 | RGD:6480464 | CTD | |
| G | CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 |
|
increases expression | ISO | 19 | 41,497,204 | 41,524,301 | RGD:6480464 | CTD | |
| G | CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 |
|
increases expression | ISO | 19 | 41,497,204 | 41,524,301 | RGD:6480464 | CTD | |
| G | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 |
|
affects expression | ISO | 10 | 96,443,251 | 96,495,947 | RGD:6480464 | CTD | |
| G | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 |
|
affects expression | ISO | 10 | 96,443,251 | 96,495,947 | RGD:6480464 | CTD | |
| G | CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 |
|
increases expression | ISO | 10 | 96,443,251 | 96,495,947 | RGD:6480464 | CTD | |
| G | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
affects expression | ISO | 10 | 96,522,463 | 96,612,671 | RGD:6480464 | CTD | |
| G | CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
affects expression | ISO | 10 | 96,522,463 | 96,612,671 | RGD:6480464 | CTD | |
| G | CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
affects expression | ISO | 10 | 96,698,415 | 96,749,148 | RGD:6480464 | CTD | |
| G | CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
increases expression | ISO | 10 | 96,698,415 | 96,749,148 | RGD:6480464 | CTD | |
| G | CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
decreases expression | ISO | 22 | 42,522,501 | 42,526,883 | RGD:6480464 | CTD | |
| G | CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
affects expression | ISO | 22 | 42,522,501 | 42,526,883 | RGD:6480464 | CTD | |
| G | CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
decreases expression | ISO | 22 | 42,522,501 | 42,526,883 | RGD:6480464 | CTD | |
| G | CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
decreases expression | ISO | 22 | 42,522,501 | 42,526,883 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
decreases expression | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects expression | ISO | 10 | 135,340,867 | 135,352,620 | RGD:6480464 | CTD | |
| G | CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 |
|
affects expression | ISO | 19 | 41,620,353 | 41,634,281 | RGD:6480464 | CTD | |
| G | CYP2F1 | cytochrome P450, family 2, subfamily F, polypeptide 1 |
|
decreases expression | ISO | 19 | 41,620,353 | 41,634,281 | RGD:6480464 | CTD | |
| G | CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 |
|
increases expression | ISO | 1 | 60,358,980 | 60,392,423 | RGD:6480464 | CTD | |
| G | CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
decreases expression | ISO | 7 | 99,354,583 | 99,381,811 | RGD:6480464 | CTD | |
| G | CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 |
|
affects expression | ISO | 7 | 99,302,660 | 99,332,819 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases activity | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
affects expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
multiple interactions | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
affects expression | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression | EXP | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases activity | ISO | 1 | 47,394,846 | 47,407,156 | RGD:6480464 | CTD | |
| G | CYP4A22 | cytochrome P450, family 4, subfamily A, polypeptide 22 |
|
affects expression | ISO | 1 | 47,603,107 | 47,614,526 | RGD:6480464 | CTD | |
| G | CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 |
|
increases expression | ISO | 1 | 47,264,670 | 47,285,021 | RGD:6480464 | CTD | |
| G | CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 |
|
decreases expression | ISO | 19 | 16,023,180 | 16,045,676 | RGD:6480464 | CTD | |
| G | CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 |
|
multiple interactions | ISO | 19 | 16,023,180 | 16,045,676 | RGD:6480464 | CTD | |
| G | CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 |
|
decreases expression | ISO | 19 | 15,783,828 | 15,807,984 | RGD:6480464 | CTD | |
| G | CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 |
|
decreases expression | ISO | 19 | 15,783,828 | 15,807,984 | RGD:6480464 | CTD | |
| G | CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 |
|
multiple interactions | ISO | 19 | 15,783,828 | 15,807,984 | RGD:6480464 | CTD | |
| G | CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 |
|
affects expression | ISO | 19 | 15,988,834 | 16,008,884 | RGD:6480464 | CTD | |
| G | CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
decreases expression | ISO | 19 | 15,751,707 | 15,771,570 | RGD:6480464 | CTD | |
| G | CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
affects expression | ISO | 19 | 15,726,029 | 15,740,448 | RGD:6480464 | CTD | |
| G | CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 |
|
decreases expression | ISO | 7 | 91,741,463 | 91,764,059 | RGD:6480464 | CTD | |
| G | CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 |
|
affects expression | ISO | 7 | 91,741,463 | 91,764,059 | RGD:6480464 | CTD | |
| G | CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 |
|
increases expression | ISO | 7 | 91,741,463 | 91,764,059 | RGD:6480464 | CTD | |
| G | CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 |
|
decreases expression | ISO | 8 | 59,402,737 | 59,412,720 | RGD:6480464 | CTD | |
| G | CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
affects expression | ISO | 8 | 65,508,529 | 65,711,348 | RGD:6480464 | CTD | |
| G | DIABLO | diablo, IAP-binding mitochondrial protein |
|
increases expression | ISO | 12 | 122,692,209 | 122,712,068 | RGD:6480464 | CTD | |
| G | DUSP6 | dual specificity phosphatase 6 |
|
decreases expression | ISO | 12 | 89,741,837 | 89,746,296 | RGD:6480464 | CTD | |
| G | ECH1 | enoyl CoA hydratase 1, peroxisomal |
|
multiple interactions | ISO | 19 | 39,306,062 | 39,322,497 | RGD:6480464 | CTD | |
| G | ECH1 | enoyl CoA hydratase 1, peroxisomal |
|
increases expression | ISO | 19 | 39,306,062 | 39,322,497 | RGD:6480464 | CTD | |
| G | ECH1 | enoyl CoA hydratase 1, peroxisomal |
|
increases expression | ISO | 19 | 39,306,062 | 39,322,497 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
affects expression | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
increases expression | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
increases expression | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
multiple interactions | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | ECI2 | enoyl-CoA delta isomerase 2 |
|
affects expression | ISO | 6 | 4,115,927 | 4,135,831 | RGD:6480464 | CTD | |
| G | ECI2 | enoyl-CoA delta isomerase 2 |
|
increases expression | ISO | 6 | 4,115,927 | 4,135,831 | RGD:6480464 | CTD | |
| G | ECI2 | enoyl-CoA delta isomerase 2 |
|
multiple interactions | ISO | 6 | 4,115,927 | 4,135,831 | RGD:6480464 | CTD | |
| G | EDF1 | endothelial differentiation-related factor 1 |
|
affects expression | ISO | 9 | 139,756,571 | 139,760,738 | RGD:6480464 | CTD | |
| G | EFNA1 | ephrin-A1 |
|
affects expression | ISO | 1 | 155,100,349 | 155,107,386 | RGD:6480464 | CTD | |
| G | EGF | epidermal growth factor |
|
affects expression | ISO | 4 | 110,834,040 | 110,934,118 | RGD:6480464 | CTD | |
| G | EGF | epidermal growth factor |
|
decreases expression | ISO | 4 | 110,834,040 | 110,934,118 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
decreases expression | ISO | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
increases expression | ISO | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGLN3 | egl nine homolog 3 (C. elegans) |
|
increases expression | ISO | 14 | 34,393,421 | 34,420,284 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
multiple interactions | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EIF2B3 | eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa |
|
increases expression | ISO | 1 | 45,316,194 | 45,452,394 | RGD:6480464 | CTD | |
| G | EIF2S1 | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
|
increases expression | ISO | 14 | 67,827,034 | 67,853,233 | RGD:6480464 | CTD | |
| G | EIF3D | eukaryotic translation initiation factor 3, subunit D |
|
increases expression | ISO | 22 | 36,906,897 | 36,925,277 | RGD:6480464 | CTD | |
| G | EIF4E | eukaryotic translation initiation factor 4E |
|
increases expression | ISO | 4 | 99,799,607 | 99,851,786 | RGD:6480464 | CTD | |
| G | EIF4EBP1 | eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression | ISO | 8 | 37,888,020 | 37,917,883 | RGD:6480464 | CTD | |
| G | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 |
|
affects expression | ISO | 10 | 72,163,861 | 72,188,374 | RGD:6480464 | CTD | |
| G | ELOVL1 | ELOVL fatty acid elongase 1 |
|
increases expression | ISO | 1 | 43,829,068 | 43,833,745 | RGD:6480464 | CTD | |
| G | ELOVL6 | ELOVL fatty acid elongase 6 |
|
increases expression | ISO | 4 | 110,970,229 | 111,119,820 | RGD:6480464 | CTD | |
| G | ELOVL6 | ELOVL fatty acid elongase 6 |
|
increases expression | ISO | 4 | 110,970,229 | 111,119,820 | RGD:6480464 | CTD | |
| G | ENO1 | enolase 1, (alpha) |
|
affects expression | ISO | 1 | 8,921,059 | 8,939,151 | RGD:6480464 | CTD | |
| G | ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
affects expression | ISO | 6 | 131,958,442 | 132,068,550 | RGD:6480464 | CTD | |
| G | ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
|
decreases expression | ISO | 6 | 131,958,442 | 132,068,550 | RGD:6480464 | CTD | |
| G | EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) |
|
affects expression | ISO | 1 | 225,997,797 | 226,033,264 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
affects expression | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
increases expression | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
multiple interactions | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
decreases activity | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | EPHX2 | epoxide hydrolase 2, cytoplasmic |
|
increases expression | ISO | 8 | 27,348,519 | 27,402,439 | RGD:6480464 | CTD | |
| G | ERP29 | endoplasmic reticulum protein 29 |
|
decreases expression | ISO | 12 | 112,451,152 | 112,461,024 | RGD:6480464 | CTD | |
| G | ESR1 | estrogen receptor 1 |
|
multiple interactions | EXP | 6 | 152,011,631 | 152,424,409 | RGD:6480464 | CTD | |
| G | ESR1 | estrogen receptor 1 |
|
increases expression | ISO | 6 | 152,011,631 | 152,424,409 | RGD:6480464 | CTD | |
| G | F10 | coagulation factor X |
|
affects expression | ISO | 13 | 113,777,113 | 113,803,843 | RGD:6480464 | CTD | |
| G | F10 | coagulation factor X |
|
decreases expression | ISO | 13 | 113,777,113 | 113,803,843 | RGD:6480464 | CTD | |
| G | F11 | coagulation factor XI |
|
affects expression | ISO | 4 | 187,187,118 | 187,210,835 | RGD:6480464 | CTD | |
| G | F11 | coagulation factor XI |
|
decreases expression | ISO | 4 | 187,187,118 | 187,210,835 | RGD:6480464 | CTD | |
| G | F11 | coagulation factor XI |
|
multiple interactions | ISO | 4 | 187,187,118 | 187,210,835 | RGD:6480464 | CTD | |
| G | F13B | coagulation factor XIII, B polypeptide |
|
affects expression | ISO | 1 | 197,008,321 | 197,036,397 | RGD:6480464 | CTD | |
| G | F2 | coagulation factor II (thrombin) |
|
affects expression | ISO | 11 | 46,740,743 | 46,761,056 | RGD:6480464 | CTD | |
| G | F5 | coagulation factor V (proaccelerin, labile factor) |
|
affects expression | ISO | 1 | 169,481,192 | 169,555,769 | RGD:6480464 | CTD | |
| G | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
|
decreases expression | ISO | 13 | 113,760,102 | 113,774,995 | RGD:6480464 | CTD | |
| G | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
|
affects expression | ISO | 13 | 113,760,102 | 113,774,995 | RGD:6480464 | CTD | |
| G | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
|
multiple interactions | ISO | 13 | 113,760,102 | 113,774,995 | RGD:6480464 | CTD | |
| G | FAAH | fatty acid amide hydrolase |
|
decreases expression | ISO | 1 | 46,859,939 | 46,879,520 | RGD:6480464 | CTD | |
| G | FABP1 | fatty acid binding protein 1, liver |
|
affects expression | ISO | 2 | 88,422,501 | 88,427,650 | RGD:6480464 | CTD | |
| G | FABP1 | fatty acid binding protein 1, liver |
|
increases expression | ISO | 2 | 88,422,501 | 88,427,650 | RGD:6480464 | CTD | |
| G | FABP2 | fatty acid binding protein 2, intestinal |
|
increases expression | ISO | 4 | 120,238,405 | 120,243,316 | RGD:6480464 | CTD | |
| G | FABP2 | fatty acid binding protein 2, intestinal |
|
multiple interactions | ISO | 4 | 120,238,405 | 120,243,316 | RGD:6480464 | CTD | |
| G | FABP3 | fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
|
increases expression | ISO | 1 | 31,838,100 | 31,845,923 | RGD:6480464 | CTD | |
| G | FABP4 | fatty acid binding protein 4, adipocyte |
|
increases expression | ISO | 8 | 82,390,732 | 82,395,473 | RGD:6480464 | CTD | |
| G | FABP4 | fatty acid binding protein 4, adipocyte |
|
multiple interactions | ISO | 8 | 82,390,732 | 82,395,473 | RGD:6480464 | CTD | |
| G | FABP4 | fatty acid binding protein 4, adipocyte |
|
increases expression | ISO | 8 | 82,390,732 | 82,395,473 | RGD:6480464 | CTD | |
| G | FABP5 | fatty acid binding protein 5 (psoriasis-associated) |
|
increases expression | ISO | 8 | 82,192,718 | 82,197,012 | RGD:6480464 | CTD | |
| G | FAM203A | family with sequence similarity 203, member A |
|
increases expression | ISO | 8 | 145,192,672 | 145,195,620 | RGD:6480464 | CTD | |
| G | FAM96B | family with sequence similarity 96, member B |
|
increases expression | ISO | 16 | 66,965,958 | 66,968,326 | RGD:6480464 | CTD | |
| G | FASN | fatty acid synthase |
|
decreases expression | ISO | 17 | 80,036,214 | 80,056,106 | RGD:6480464 | CTD | |
| G | FAT2 | FAT tumor suppressor homolog 2 (Drosophila) |
|
increases expression | ISO | 5 | 150,883,653 | 150,948,505 | RGD:6480464 | CTD | |
| G | FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed |
|
increases expression | ISO | 11 | 64,888,099 | 64,889,672 | RGD:6480464 | CTD | |
| G | FBP1 | fructose-1,6-bisphosphatase 1 |
|
decreases expression | ISO | 9 | 97,365,415 | 97,402,531 | RGD:6480464 | CTD | |
| G | FBP1 | fructose-1,6-bisphosphatase 1 |
|
multiple interactions | ISO | 9 | 97,365,415 | 97,402,531 | RGD:6480464 | CTD | |
| G | FBP2 | fructose-1,6-bisphosphatase 2 |
|
affects expression | ISO | 9 | 97,321,002 | 97,356,075 | RGD:6480464 | CTD | |
| G | FBP2 | fructose-1,6-bisphosphatase 2 |
|
increases expression | ISO | 9 | 97,321,002 | 97,356,075 | RGD:6480464 | CTD | |
| G | FBXO21 | F-box protein 21 |
|
increases expression | ISO | 12 | 117,581,585 | 117,628,300 | RGD:6480464 | CTD | |
| G | FBXO30 | F-box protein 30 |
|
increases expression | ISO | 6 | 146,119,271 | 146,135,921 | RGD:6480464 | CTD | |
| G | FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) |
|
decreases expression | ISO | 1 | 161,475,205 | 161,489,360 | RGD:6480464 | CTD | |
| G | FDFT1 | farnesyl-diphosphate farnesyltransferase 1 |
|
decreases expression | ISO | 8 | 11,660,190 | 11,696,818 | RGD:6480464 | CTD | |
| G | FDPS | farnesyl diphosphate synthase |
|
increases expression | ISO | 1 | 155,278,539 | 155,290,457 | RGD:6480464 | CTD | |
| G | GLUL | glutamate-ammonia ligase |
|
decreases expression | ISO | 1 | 182,350,839 | 182,361,341 | RGD:6480464 | CTD | |
| G | GM2A | GM2 ganglioside activator |
|
decreases expression | ISO | 5 | 150,632,613 | 150,649,955 | RGD:6480464 | CTD | |
| G | GMFB | glia maturation factor, beta |
|
increases expression | ISO | 14 | 54,941,209 | 54,955,744 | RGD:6480464 | CTD | |
| G | GNA13 | guanine nucleotide binding protein (G protein), alpha 13 |
|
affects expression | ISO | 17 | 63,005,407 | 63,052,920 | RGD:6480464 | CTD | |
| G | GNAI1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
increases expression | ISO | 7 | 79,764,140 | 79,848,725 | RGD:6480464 | CTD | |
| G | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
increases expression | ISO | 1 | 1,716,725 | 1,822,526 | RGD:6480464 | CTD | |
| G | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
decreases expression | ISO | 9 | 36,214,438 | 36,277,053 | RGD:6480464 | CTD | |
| G | GNL3 | guanine nucleotide binding protein-like 3 (nucleolar) |
|
increases expression | ISO | 3 | 52,719,936 | 52,728,513 | RGD:6480464 | CTD | |
| G | GOPC | golgi-associated PDZ and coiled-coil motif containing |
|
affects expression | ISO | 6 | 117,881,432 | 117,923,705 | RGD:6480464 | CTD | |
| G | GPAM | glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression | ISO | 10 | 113,909,622 | 113,943,537 | RGD:6480464 | CTD | |
| G | GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
increases expression | ISO | 12 | 50,497,602 | 50,505,103 | RGD:6480464 | CTD | |
| G | GPD2 | glycerol-3-phosphate dehydrogenase 2 (mitochondrial) |
|
increases expression | ISO | 2 | 157,291,965 | 157,442,915 | RGD:6480464 | CTD | |
| G | GPI | glucose-6-phosphate isomerase |
|
affects expression | ISO | 19 | 34,855,645 | 34,893,318 | RGD:6480464 | CTD | |
| G | GPRC5C | G protein-coupled receptor, family C, group 5, member C |
|
decreases expression | ISO | 17 | 72,427,667 | 72,443,568 | RGD:6480464 | CTD | |
| G | GPX2 | glutathione peroxidase 2 (gastrointestinal) |
|
multiple interactions | ISO | 14 | 65,405,870 | 65,409,623 | RGD:6480464 | CTD | |
| G | GPX2 | glutathione peroxidase 2 (gastrointestinal) |
|
increases expression | ISO | 14 | 65,405,870 | 65,409,623 | RGD:6480464 | CTD | |
| G | GPX4 | glutathione peroxidase 4 |
|
affects expression | ISO | 19 | 1,103,936 | 1,106,787 | RGD:6480464 | CTD | |
| G | GRB10 | growth factor receptor-bound protein 10 |
|
increases expression | ISO | 7 | 50,657,760 | 50,861,159 | RGD:6480464 | CTD | |
| G | GRB2 | growth factor receptor-bound protein 2 |
|
decreases expression | ISO | 17 | 73,314,157 | 73,401,790 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
increases activity | EXP | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
affects expression | ISO | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSS | glutathione synthetase |
|
increases expression | ISO | 20 | 33,516,236 | 33,543,601 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
increases expression | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
affects expression | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
increases expression | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
affects expression | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
multiple interactions | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
decreases expression | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA4 | glutathione S-transferase alpha 4 |
|
affects expression | ISO | 6 | 52,842,746 | 52,860,178 | RGD:6480464 | CTD | |
| G | GSTA4 | glutathione S-transferase alpha 4 |
|
decreases expression | ISO | 6 | 52,842,746 | 52,860,178 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
increases expression | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
increases expression | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
multiple interactions | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | GSTA5 | glutathione S-transferase alpha 5 |
|
increases expression | ISO | 6 | 52,696,540 | 52,710,893 | RGD:6480464 | CTD | |
| G | GSTK1 | glutathione S-transferase kappa 1 |
|
affects expression | ISO | 7 | 142,960,522 | 142,966,222 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
decreases expression | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects expression | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
multiple interactions | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
affects expression | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
decreases expression | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
multiple interactions | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
affects expression | ISO | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
multiple interactions | ISO | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
multiple interactions | ISO | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
increases expression | ISO | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
affects expression | ISO | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
multiple interactions | ISO | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
increases expression | ISO | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
multiple interactions | ISO | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
increases expression | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects expression | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
multiple interactions | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTT1 | glutathione S-transferase theta 1 |
|
affects expression | ISO | 22 | 24,376,139 | 24,384,284 | RGD:6480464 | CTD | |
| G | GSTT2 | glutathione S-transferase theta 2 |
|
multiple interactions | ISO | 22 | 24,322,314 | 24,326,106 | RGD:6480464 | CTD | |
| G | GSTT2 | glutathione S-transferase theta 2 |
|
affects expression | ISO | 22 | 24,322,314 | 24,326,106 | RGD:6480464 | CTD | |
| G | GSTT2 | glutathione S-transferase theta 2 |
|
increases expression | ISO | 22 | 24,322,314 | 24,326,106 | RGD:6480464 | CTD | |
| G | GTF2B | general transcription factor IIB |
|
increases expression | ISO | 1 | 89,318,321 | 89,357,301 | RGD:6480464 | CTD | |
| G | GUCY1A3 | guanylate cyclase 1, soluble, alpha 3 |
|
decreases expression | ISO | 4 | 156,587,862 | 156,658,214 | RGD:6480464 | CTD | |
| G | GUCY1B2 | guanylate cyclase 1, soluble, beta 2 (pseudogene) |
|
decreases expression | ISO | 13 | 51,568,647 | 51,640,293 | RGD:6480464 | CTD | |
| G | GUCY2C | guanylate cyclase 2C (heat stable enterotoxin receptor) |
|
affects expression | ISO | 12 | 14,765,566 | 14,849,519 | RGD:6480464 | CTD | |
| G | GULOP | gulonolactone (L-) oxidase, pseudogene |
|
decreases expression | ISO | 8 | 27,435,128 | 27,446,590 | RGD:6480464 | CTD | |
| G | GYS2 | glycogen synthase 2 (liver) |
|
increases expression | ISO | 12 | 21,689,123 | 21,757,781 | RGD:6480464 | CTD | |
| G | H2AFV | H2A histone family, member V |
|
decreases expression | ISO | 7 | 44,866,488 | 44,887,725 | RGD:6480464 | CTD | |
| G | H3F3B | H3 histone, family 3B (H3.3B) |
|
increases expression | ISO | 17 | 73,772,515 | 73,775,860 | RGD:6480464 | CTD | |
| G | HACL1 | 2-hydroxyacyl-CoA lyase 1 |
|
increases expression | ISO | 3 | 15,602,239 | 15,643,130 | RGD:6480464 | CTD | |
| G | HADH | hydroxyacyl-CoA dehydrogenase |
|
affects expression | ISO | 4 | 108,910,870 | 108,956,331 | RGD:6480464 | CTD | |
| G | HADHA | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
increases expression | ISO | 2 | 26,413,504 | 26,467,594 | RGD:6480464 | CTD | |
| G | HADHA | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
multiple interactions | ISO | 2 | 26,413,504 | 26,467,594 | RGD:6480464 | CTD | |
| G | HADHA | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
increases expression | ISO | 2 | 26,413,504 | 26,467,594 | RGD:6480464 | CTD | |
| G | HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
increases expression | ISO | 2 | 26,467,616 | 26,513,333 | RGD:6480464 | CTD | |
| G | HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
multiple interactions | ISO | 2 | 26,467,616 | 26,513,333 | RGD:6480464 | CTD | |
| G | HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
|
increases expression | ISO | 2 | 26,467,616 | 26,513,333 | RGD:6480464 | CTD | |
| G | HAL | histidine ammonia-lyase |
|
decreases expression | ISO | 12 | 96,366,440 | 96,390,143 | RGD:6480464 | CTD | |
| G | HAL | histidine ammonia-lyase |
|
affects expression | ISO | 12 | 96,366,440 | 96,390,143 | RGD:6480464 | CTD | |
| G | HBE1 | hemoglobin, epsilon 1 |
|
affects expression | ISO | 11 | 5,289,580 | 5,291,373 | RGD:6480464 | CTD | |
| G | HDC | histidine decarboxylase |
|
increases expression | ISO | 15 | 50,534,144 | 50,558,162 | RGD:6480464 | CTD | |
| G | HEXB | hexosaminidase B (beta polypeptide) |
|
decreases expression | ISO | 5 | 73,980,969 | 74,017,113 | RGD:6480464 | CTD | |
| G | HGF | hepatocyte growth factor (hepapoietin A; scatter factor) |
|
increases expression | ISO | 7 | 81,331,444 | 81,399,452 | RGD:6480464 | CTD | |
| G | HGS | hepatocyte growth factor-regulated tyrosine kinase substrate |
|
increases expression | ISO | 17 | 79,650,962 | 79,669,151 | RGD:6480464 | CTD | |
| G | HIGD1A | HIG1 hypoxia inducible domain family, member 1A |
|
increases expression | ISO | 3 | 42,824,400 | 42,846,027 | RGD:6480464 | CTD | |
| G | HIGD1A | HIG1 hypoxia inducible domain family, member 1A |
|
increases expression | ISO | 3 | 42,824,400 | 42,846,027 | RGD:6480464 | CTD | |
| G | HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase |
|
affects expression | ISO | 1 | 24,128,367 | 24,151,949 | RGD:6480464 | CTD | |
| G | HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) |
|
increases expression | ISO | 2 | 198,364,721 | 198,368,187 | RGD:6480464 | CTD | |
| G | HSPH1 | heat shock 105kDa/110kDa protein 1 |
|
increases expression | ISO | 13 | 31,710,762 | 31,736,117 | RGD:6480464 | CTD | |
| G | ICA1 | islet cell autoantigen 1, 69kDa |
|
increases expression | ISO | 7 | 8,152,814 | 8,302,185 | RGD:6480464 | CTD | |
| G | ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
|
increases expression | ISO | 20 | 30,193,086 | 30,194,318 | RGD:6480464 | CTD | |
| G | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
affects expression | ISO | 2 | 8,822,113 | 8,824,583 | RGD:6480464 | CTD | |
| G | ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
|
decreases expression | ISO | 1 | 23,884,421 | 23,886,285 | RGD:6480464 | CTD | |
| G | IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
decreases expression | ISO | 15 | 90,627,210 | 90,645,708 | RGD:6480464 | CTD | |
| G | IDI1 | isopentenyl-diphosphate delta isomerase 1 |
|
increases expression | ISO | 10 | 1,085,963 | 1,095,061 | RGD:6480464 | CTD | |
| G | IDI1 | isopentenyl-diphosphate delta isomerase 1 |
|
decreases expression | ISO | 10 | 1,085,963 | 1,095,061 | RGD:6480464 | CTD | |
| G | IER3 | immediate early response 3 |
|
decreases expression | ISO | 6 | 30,710,976 | 30,712,327 | RGD:6480464 | CTD | |
| G | IER5 | immediate early response 5 |
|
affects expression | ISO | 1 | 181,057,638 | 181,059,979 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
decreases expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IFNA5 | interferon, alpha 5 |
|
affects expression | ISO | 9 | 21,304,613 | 21,305,312 | RGD:6480464 | CTD | |
| G | IFRD1 | interferon-related developmental regulator 1 |
|
increases expression | ISO | 7 | 112,063,199 | 112,117,258 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
increases expression | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
increases expression | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGF1 | insulin-like growth factor 1 (somatomedin C) |
|
decreases expression | ISO | 12 | 102,789,645 | 102,874,378 | RGD:6480464 | CTD | |
| G | IGFALS | insulin-like growth factor binding protein, acid labile subunit |
|
decreases expression | ISO | 16 | 1,840,414 | 1,844,909 | RGD:6480464 | CTD | |
| G | IGFBP2 | insulin-like growth factor binding protein 2, 36kDa |
|
increases expression | ISO | 2 | 217,498,127 | 217,529,159 | RGD:6480464 | CTD | |
| G | IGFBP3 | insulin-like growth factor binding protein 3 |
|
decreases expression | ISO | 7 | 45,951,844 | 45,960,871 | RGD:6480464 | CTD | |
| G | IL10 | interleukin 10 |
|
decreases secretion | EXP | 1 | 206,940,948 | 206,945,839 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL2RB | interleukin 2 receptor, beta |
|
decreases expression | ISO | 22 | 37,521,878 | 37,545,962 | RGD:6480464 | CTD | |
| G | IL33 | interleukin 33 |
|
decreases expression | ISO | 9 | 6,215,786 | 6,257,983 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
decreases secretion | EXP | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
multiple interactions | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IMP3 | IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
|
increases expression | ISO | 15 | 75,931,426 | 75,932,664 | RGD:6480464 | CTD | |
| G | IMPA2 | inositol(myo)-1(or 4)-monophosphatase 2 |
|
increases expression | ISO | 18 | 11,981,427 | 12,030,885 | RGD:6480464 | CTD | |
| G | INHBA | inhibin, beta A |
|
decreases expression | ISO | 7 | 41,728,601 | 41,742,706 | RGD:6480464 | CTD | |
| G | INMT | indolethylamine N-methyltransferase |
|
affects expression | ISO | 7 | 30,791,751 | 30,797,218 | RGD:6480464 | CTD | |
| G | INPP5D | inositol polyphosphate-5-phosphatase, 145kDa |
|
decreases expression | ISO | 2 2 |
233,925,036 234,054,795 |
233,995,880 234,116,549 |
RGD:6480464 | CTD | |
| G | INSIG1 | insulin induced gene 1 |
|
decreases expression | ISO | 7 | 155,089,486 | 155,101,945 | RGD:6480464 | CTD | |
| G | INTS1 | integrator complex subunit 1 |
|
affects expression | ISO | 7 | 1,509,913 | 1,544,018 | RGD:6480464 | CTD | |
| G | IREB2 | iron-responsive element binding protein 2 |
|
increases expression | ISO | 15 | 78,730,518 | 78,793,798 | RGD:6480464 | CTD | |
| G | IRF1 | interferon regulatory factor 1 |
|
decreases expression | ISO | 5 | 131,817,301 | 131,826,465 | RGD:6480464 | CTD | |
| G | IRF3 | interferon regulatory factor 3 |
|
decreases expression | ISO | 19 | 50,162,826 | 50,169,132 | RGD:6480464 | CTD | |
| G | ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
decreases expression | ISO | 3 | 52,847,006 | 52,864,717 | RGD:6480464 | CTD | |
| G | IVD | isovaleryl-CoA dehydrogenase |
|
affects expression | ISO | 15 | 40,697,686 | 40,713,512 | RGD:6480464 | CTD | |
| G | IVD | isovaleryl-CoA dehydrogenase |
|
decreases expression | ISO | 15 | 40,697,686 | 40,713,512 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
increases expression | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
multiple interactions | ISO | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | JUNB | jun B proto-oncogene |
|
decreases expression | ISO | 19 | 12,902,310 | 12,904,125 | RGD:6480464 | CTD | |
| G | KCNJ8 | potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases expression | ISO | 12 | 21,917,889 | 21,927,755 | RGD:6480464 | CTD | |
| G | KCNN2 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
|
decreases expression | ISO | 5 | 113,698,016 | 113,832,197 | RGD:6480464 | CTD | |
| G | KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
decreases expression | ISO | 4 | 55,944,426 | 55,991,762 | RGD:6480464 | CTD | |
| G | KHK | ketohexokinase (fructokinase) |
|
decreases expression | ISO | 2 | 27,309,611 | 27,323,619 | RGD:6480464 | CTD | |
| G | KIF13A | kinesin family member 13A |
|
affects expression | ISO | 6 | 17,759,414 | 17,987,854 | RGD:6480464 | CTD | |
| G | KIRREL3 | kin of IRRE like 3 (Drosophila) |
|
affects expression | ISO | 11 | 126,293,396 | 126,870,766 | RGD:6480464 | CTD | |
| G | KLC1 | kinesin light chain 1 |
|
increases expression | ISO | 14 | 104,095,525 | 104,167,888 | RGD:6480464 | CTD | |
| G | KLF10 | Kruppel-like factor 10 |
|
increases expression | ISO | 8 | 103,661,005 | 103,667,983 | RGD:6480464 | CTD | |
| G | KLF6 | Kruppel-like factor 6 |
|
increases expression | ISO | 10 | 3,818,188 | 3,827,473 | RGD:6480464 | CTD | |
| G | KLKB1 | kallikrein B, plasma (Fletcher factor) 1 |
|
affects expression | ISO | 4 | 187,148,672 | 187,179,625 | RGD:6480464 | CTD | |
| G | KLKB1 | kallikrein B, plasma (Fletcher factor) 1 |
|
multiple interactions | ISO | 4 | 187,148,672 | 187,179,625 | RGD:6480464 | CTD | |
| G | KLKB1 | kallikrein B, plasma (Fletcher factor) 1 |
|
decreases expression | ISO | 4 | 187,148,672 | 187,179,625 | RGD:6480464 | CTD | |
| G | KLKB1 | kallikrein B, plasma (Fletcher factor) 1 |
|
decreases expression | ISO | 4 | 187,148,672 | 187,179,625 | RGD:6480464 | CTD | |
| G | KMO | kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
|
decreases expression | ISO | 1 | 241,695,434 | 241,758,949 | RGD:6480464 | CTD | |
| G | KRT18 | keratin 18 |
|
increases expression | ISO | 12 | 53,342,655 | 53,346,685 | RGD:6480464 | CTD | |
| G | KRT8 | keratin 8 |
|
increases expression | ISO | 12 | 53,290,971 | 53,343,650 | RGD:6480464 | CTD | |
| G | KTI12 | KTI12 homolog, chromatin associated (S. cerevisiae) |
|
increases expression | ISO | 1 | 52,497,777 | 52,499,472 | RGD:6480464 | CTD | |
| G | KYNU | kynureninase |
|
decreases expression | ISO | 2 | 143,635,195 | 143,799,885 | RGD:6480464 | CTD | |
| G | LALBA | lactalbumin, alpha- |
|
affects expression | ISO | 12 | 48,961,467 | 48,963,829 | RGD:6480464 | CTD | |
| G | LASP1 | LIM and SH3 protein 1 |
|
affects expression | ISO | 17 | 37,026,112 | 37,078,023 | RGD:6480464 | CTD | |
| G | LCAT | lecithin-cholesterol acyltransferase |
|
decreases expression | ISO | 16 | 67,973,787 | 67,978,015 | RGD:6480464 | CTD | |
| G | LCAT | lecithin-cholesterol acyltransferase |
|
decreases expression | ISO | 16 | 67,973,787 | 67,978,015 | RGD:6480464 | CTD | |
| G | LDHA | lactate dehydrogenase A |
|
affects expression | ISO | 11 | 18,415,936 | 18,429,765 | RGD:6480464 | CTD | |
| G | LDLR | low density lipoprotein receptor |
|
increases expression | ISO | 19 | 11,200,038 | 11,244,506 | RGD:6480464 | CTD | |
| G | LEF1 | lymphoid enhancer-binding factor 1 |
|
affects expression | ISO | 4 | 108,968,701 | 109,090,112 | RGD:6480464 | CTD | |
| G | LENEP | lens epithelial protein |
|
increases expression | ISO | 1 | 154,966,062 | 154,966,791 | RGD:6480464 | CTD | |
| G | LEPR | leptin receptor |
|
increases expression | ISO | 1 | 65,886,335 | 66,103,176 | RGD:6480464 | CTD | |
| G | LGR4 | leucine-rich repeat containing G protein-coupled receptor 4 |
|
decreases expression | ISO | 11 | 27,387,508 | 27,494,334 | RGD:6480464 | CTD | |
| G | LIMA1 | LIM domain and actin binding 1 |
|
affects expression | ISO | 12 | 50,569,563 | 50,677,353 | RGD:6480464 | CTD | |
| G | LIMK2 | LIM domain kinase 2 |
|
increases expression | ISO | 22 | 31,608,250 | 31,676,066 | RGD:6480464 | CTD | |
| G | LIN7A | lin-7 homolog A (C. elegans) |
|
decreases expression | ISO | 12 | 81,191,171 | 81,331,694 | RGD:6480464 | CTD | |
| G | LIPC | lipase, hepatic |
|
decreases expression | ISO | 15 | 58,724,175 | 58,861,073 | RGD:6480464 | CTD | |
| G | LOX | lysyl oxidase |
|
decreases expression | ISO | 5 | 121,398,890 | 121,414,055 | RGD:6480464 | CTD | |
| G | LPL | lipoprotein lipase |
|
increases expression | ISO | 8 | 19,796,582 | 19,824,770 | RGD:6480464 | CTD | |
| G | LPO | lactoperoxidase |
|
multiple interactions | ISO | 17 | 56,315,787 | 56,345,879 | RGD:6480464 | CTD | |
| G | LRP2 | low density lipoprotein receptor-related protein 2 |
|
affects expression | ISO | 2 | 169,983,619 | 170,219,122 | RGD:6480464 | CTD | |
| G | LRP4 | low density lipoprotein receptor-related protein 4 |
|
decreases expression | ISO | 11 | 46,878,268 | 46,940,173 | RGD:6480464 | CTD | |
| G | LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression | ISO | 21 | 47,608,360 | 47,648,738 | RGD:6480464 | CTD | |
| G | LTA4H | leukotriene A4 hydrolase |
|
affects expression | ISO | 12 | 96,394,531 | 96,437,298 | RGD:6480464 | CTD | |
| G | LTA4H | leukotriene A4 hydrolase |
|
decreases expression | ISO | 12 | 96,394,531 | 96,437,298 | RGD:6480464 | CTD | |
| G | LTF | lactotransferrin |
|
affects expression | ISO | 3 | 46,477,496 | 46,506,598 | RGD:6480464 | CTD | |
| G | MPC1 | mitochondrial pyruvate carrier 1 |
|
decreases expression | ISO | 6 | 166,778,407 | 166,796,501 | RGD:6480464 | CTD | |
| G | MRTO4 | mRNA turnover 4 homolog (S. cerevisiae) |
|
increases expression | ISO | 1 | 19,578,075 | 19,586,622 | RGD:6480464 | CTD | |
| G | MT-ND1 | mitochondrially encoded NADH dehydrogenase 1 |
|
increases expression | ISO | MT | 3,307 | 4,262 | RGD:6480464 | CTD | |
| G | MTCH2 | mitochondrial carrier 2 |
|
decreases expression | ISO | 11 | 47,638,858 | 47,664,206 | RGD:6480464 | CTD | |
| G | MTMR6 | myotubularin related protein 6 |
|
decreases expression | ISO | 13 | 25,820,339 | 25,861,704 | RGD:6480464 | CTD | |
| G | MTMR7 | myotubularin related protein 7 |
|
decreases expression | ISO | 8 | 17,154,306 | 17,271,040 | RGD:6480464 | CTD | |
| G | MTMR7 | myotubularin related protein 7 |
|
affects expression | ISO | 8 | 17,154,306 | 17,271,040 | RGD:6480464 | CTD | |
| G | MTMR7 | myotubularin related protein 7 |
|
decreases expression | ISO | 8 | 17,154,306 | 17,271,040 | RGD:6480464 | CTD | |
| G | MTTP | microsomal triglyceride transfer protein |
|
affects expression | ISO | 4 | 100,485,240 | 100,545,154 | RGD:6480464 | CTD | |
| G | MTTP | microsomal triglyceride transfer protein |
|
increases expression | ISO | 4 | 100,485,240 | 100,545,154 | RGD:6480464 | CTD | |
| G | MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
|
decreases expression | ISO | 21 | 42,792,520 | 42,831,141 | RGD:6480464 | CTD | |
| G | MXD4 | MAX dimerization protein 4 |
|
decreases expression | ISO | 4 | 2,249,160 | 2,263,739 | RGD:6480464 | CTD | |
| G | MXD4 | MAX dimerization protein 4 |
|
decreases expression | ISO | 4 | 2,249,160 | 2,263,739 | RGD:6480464 | CTD | |
| G | MYBBP1A | MYB binding protein (P160) 1a |
|
increases expression | ISO | 17 | 4,442,191 | 4,458,681 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression | ISO | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | MYL9 | myosin, light chain 9, regulatory |
|
decreases expression | ISO | 20 | 35,169,887 | 35,178,226 | RGD:6480464 | CTD | |
| G | MYLK2 | myosin light chain kinase 2 |
|
decreases expression | ISO | 20 | 30,407,178 | 30,422,500 | RGD:6480464 | CTD | |
| G | MYO1G | myosin IG |
|
increases expression | ISO | 7 | 45,002,260 | 45,018,704 | RGD:6480464 | CTD | |
| G | MYO5B | myosin VB |
|
increases expression | ISO | 18 | 47,349,156 | 47,721,451 | RGD:6480464 | CTD | |
| G | NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
|
increases expression | ISO | 4 | 140,222,676 | 140,311,935 | RGD:6480464 | CTD | |
| G | NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit |
|
increases expression | ISO | 20 | 19,997,934 | 20,014,273 | RGD:6480464 | CTD | |
| G | NAP1L1 | nucleosome assembly protein 1-like 1 |
|
increases expression | ISO | 12 | 76,438,672 | 76,478,738 | RGD:6480464 | CTD | |
| G | NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
multiple interactions | ISO | 8 | 18,248,755 | 18,258,723 | RGD:6480464 | CTD | |
| G | NAT2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
decreases expression | ISO | 8 | 18,248,755 | 18,258,723 | RGD:6480464 | CTD | |
| G | NCDN | neurochondrin |
|
increases expression | ISO | 1 | 36,023,393 | 36,032,380 | RGD:6480464 | CTD | |
| G | NCL | nucleolin |
|
increases expression | ISO | 2 | 232,319,459 | 232,329,205 | RGD:6480464 | CTD | |
| G | NCOR1 | nuclear receptor corepressor 1 |
|
affects expression | ISO | 17 | 15,933,408 | 16,118,874 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
affects expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFIB | nuclear factor I/B |
|
affects expression | ISO | 9 | 14,081,842 | 14,398,982 | RGD:6480464 | CTD | |
| G | NMT1 | N-myristoyltransferase 1 |
|
increases expression | ISO | 17 | 43,138,680 | 43,186,384 | RGD:6480464 | CTD | |
| G | NNT | nicotinamide nucleotide transhydrogenase |
|
decreases expression | ISO | 5 | 43,602,791 | 43,705,668 | RGD:6480464 | CTD | |
| G | NOLC1 | nucleolar and coiled-body phosphoprotein 1 |
|
increases expression | ISO | 10 | 103,911,933 | 103,923,627 | RGD:6480464 | CTD | |
| G | NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression | ISO | 5 | 170,814,708 | 170,837,888 | RGD:6480464 | CTD | |
| G | NPNT | nephronectin |
|
affects expression | ISO | 4 | 106,816,597 | 106,892,828 | RGD:6480464 | CTD | |
| G | NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
decreases expression | ISO | 1 | 153,651,164 | 153,666,468 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
affects expression | ISO | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NR1D2 | nuclear receptor subfamily 1, group D, member 2 |
|
increases expression | ISO | 3 | 23,986,751 | 24,022,109 | RGD:6480464 | CTD | |
| G | NR1H3 | nuclear receptor subfamily 1, group H, member 3 |
|
decreases expression | ISO | 11 | 47,269,851 | 47,290,584 | RGD:6480464 | CTD | |
| G | NR1H4 | nuclear receptor subfamily 1, group H, member 4 |
|
decreases expression | ISO | 12 | 100,867,551 | 100,957,645 | RGD:6480464 | CTD | |
| G | NR1I2 | nuclear receptor subfamily 1, group I, member 2 |
|
increases expression | ISO | 3 | 119,499,331 | 119,537,332 | RGD:6480464 | CTD | |
| G | NR1I2 | nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions | ISO | 3 | 119,499,331 | 119,537,332 | RGD:6480464 | CTD | |
| G | NR1I3 | nuclear receptor subfamily 1, group I, member 3 |
|
increases expression | ISO | 1 | 161,199,456 | 161,208,000 | RGD:6480464 | CTD | |
| G | NR1I3 | nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions | ISO | 1 | 161,199,456 | 161,208,000 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression | ISO | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression | ISO | 12 | 52,416,616 | 52,453,291 | RGD:6480464 | CTD | |
| G | NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
|
affects expression | ISO | 2 | 157,180,944 | 157,189,287 | RGD:6480464 | CTD | |
| G | NRG1 | neuregulin 1 |
|
increases expression | ISO | 8 | 31,496,820 | 32,622,558 | RGD:6480464 | CTD | |
| G | NRP1 | neuropilin 1 |
|
affects expression | ISO | 10 | 33,466,419 | 33,623,833 | RGD:6480464 | CTD | |
| G | NRP1 | neuropilin 1 |
|
decreases expression | ISO | 10 | 33,466,419 | 33,623,833 | RGD:6480464 | CTD | |
| G | NSFL1C | NSFL1 (p97) cofactor (p47) |
|
increases expression | ISO | 20 | 1,422,807 | 1,448,337 | RGD:6480464 | CTD | |
| G | NSUN4 | NOP2/Sun domain family, member 4 |
|
increases expression | ISO | 1 | 46,805,849 | 46,830,824 | RGD:6480464 | CTD | |
| G | NT5E | 5'-nucleotidase, ecto (CD73) |
|
affects expression | ISO | 6 | 86,159,302 | 86,205,509 | RGD:6480464 | CTD | |
| G | NUP153 | nucleoporin 153kDa |
|
increases expression | ISO | 6 | 17,615,269 | 17,706,818 | RGD:6480464 | CTD | |
| G | NUP88 | nucleoporin 88kDa |
|
decreases expression | ISO | 17 | 5,289,346 | 5,323,059 | RGD:6480464 | CTD | |
| G | NUP98 | nucleoporin 98kDa |
|
increases expression | ISO | 11 | 3,696,240 | 3,819,022 | RGD:6480464 | CTD | |
| G | NUPR1 | nuclear protein, transcriptional regulator, 1 |
|
increases expression | ISO | 16 | 28,548,662 | 28,550,495 | RGD:6480464 | CTD | |
| G | OAT | ornithine aminotransferase |
|
affects expression | ISO | 10 | 126,085,872 | 126,107,545 | RGD:6480464 | CTD | |
| G | OAT | ornithine aminotransferase |
|
decreases expression | ISO | 10 | 126,085,872 | 126,107,545 | RGD:6480464 | CTD | |
| G | OAZ2 | ornithine decarboxylase antizyme 2 |
|
affects expression | ISO | 15 | 64,979,773 | 64,995,462 | RGD:6480464 | CTD | |
| G | ODC1 | ornithine decarboxylase 1 |
|
increases expression | ISO | 2 | 10,580,508 | 10,588,453 | RGD:6480464 | CTD | |
| G | OPRL1 | opiate receptor-like 1 |
|
decreases expression | ISO | 20 | 62,711,471 | 62,731,996 | RGD:6480464 | CTD | |
| G | OR51E2 | olfactory receptor, family 51, subfamily E, member 2 |
|
increases expression | ISO | 11 | 4,701,401 | 4,719,076 | RGD:6480464 | CTD | |
| G | OR51E2 | olfactory receptor, family 51, subfamily E, member 2 |
|
decreases expression | ISO | 11 | 4,701,401 | 4,719,076 | RGD:6480464 | CTD | |
| G | ORM2 | orosomucoid 2 |
|
decreases expression | ISO | 9 | 117,092,069 | 117,095,536 | RGD:6480464 | CTD | |
| G | ORM2 | orosomucoid 2 |
|
multiple interactions | ISO | 9 | 117,092,069 | 117,095,536 | RGD:6480464 | CTD | |
| G | ORMDL2 | ORM1-like 2 (S. cerevisiae) |
|
decreases expression | ISO | 12 | 56,211,806 | 56,214,959 | RGD:6480464 | CTD | |
| G | OTC | ornithine carbamoyltransferase |
|
decreases expression | ISO | X | 38,211,736 | 38,280,703 | RGD:6480464 | CTD | |
| G | OXNAD1 | oxidoreductase NAD-binding domain containing 1 |
|
increases expression | ISO | 3 | 16,306,667 | 16,347,594 | RGD:6480464 | CTD | |
| G | OXR1 | oxidation resistance 1 |
|
decreases expression | ISO | 8 | 107,282,406 | 107,764,922 | RGD:6480464 | CTD | |
| G | P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 |
|
decreases expression | ISO | 3 | 150,929,905 | 150,996,230 | RGD:6480464 | CTD | |
| G | PAPD7 | PAP associated domain containing 7 |
|
increases expression | ISO | 5 | 6,714,718 | 6,757,161 | RGD:6480464 | CTD | |
| G | PAPOLA | poly(A) polymerase alpha |
|
increases expression | ISO | 14 | 96,968,713 | 97,033,453 | RGD:6480464 | CTD | |
| G | PAPSS2 | 3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
decreases expression | ISO | 10 | 89,419,476 | 89,507,462 | RGD:6480464 | CTD | |
| G | PC | pyruvate carboxylase |
|
affects expression | ISO | 11 | 66,615,997 | 66,725,847 | RGD:6480464 | CTD | |
| G | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
|
decreases expression | ISO | 20 | 62,887,048 | 62,907,579 | RGD:6480464 | CTD | |
| G | PCMTD2 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
|
decreases expression | ISO | 20 | 62,887,048 | 62,907,579 | RGD:6480464 | CTD | |
| G | PCNA | proliferating cell nuclear antigen |
|
increases expression | ISO | 20 | 5,095,599 | 5,107,268 | RGD:6480464 | CTD | |
| G | PCSK1 | proprotein convertase subtilisin/kexin type 1 |
|
increases expression | ISO | 5 | 95,726,040 | 95,768,985 | RGD:6480464 | CTD | |
| G | PCSK4 | proprotein convertase subtilisin/kexin type 4 |
|
increases expression | ISO | 19 | 1,481,427 | 1,490,407 | RGD:6480464 | CTD | |
| G | PCSK5 | proprotein convertase subtilisin/kexin type 5 |
|
decreases expression | ISO | 9 | 78,505,560 | 78,977,255 | RGD:6480464 | CTD | |
| G | PCTP | phosphatidylcholine transfer protein |
|
affects expression | ISO | 17 | 53,828,340 | 53,854,748 | RGD:6480464 | CTD | |
| G | PCYT2 | phosphate cytidylyltransferase 2, ethanolamine |
|
decreases expression | ISO | 17 | 79,860,777 | 79,869,340 | RGD:6480464 | CTD | |
| G | PDE2A | phosphodiesterase 2A, cGMP-stimulated |
|
decreases expression | ISO | 11 | 72,287,184 | 72,385,497 | RGD:6480464 | CTD | |
| G | PDGFA | platelet-derived growth factor alpha polypeptide |
|
increases expression | ISO | 7 | 536,895 | 559,481 | RGD:6480464 | CTD | |
| G | PDGFC | platelet derived growth factor C |
|
affects expression | ISO | 4 | 157,682,763 | 157,892,546 | RGD:6480464 | CTD | |
| G | PDXK | pyridoxal (pyridoxine, vitamin B6) kinase |
|
increases expression | ISO | 21 | 45,138,978 | 45,182,188 | RGD:6480464 | CTD | |
| G | PLA1A | phospholipase A1 member A |
|
decreases expression | ISO | 3 | 119,316,695 | 119,348,658 | RGD:6480464 | CTD | |
| G | PLA2G6 | phospholipase A2, group VI (cytosolic, calcium-independent) |
|
increases expression | ISO | 22 | 38,507,502 | 38,577,836 | RGD:6480464 | CTD | |
| G | PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
increases expression | ISO | 6 | 46,672,053 | 46,703,430 | RGD:6480464 | CTD | |
| G | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) |
|
increases expression | ISO | 20 | 8,113,296 | 8,865,547 | RGD:6480464 | CTD | |
| G | PLCB4 | phospholipase C, beta 4 |
|
decreases expression | ISO | 20 | 9,049,701 | 9,461,463 | RGD:6480464 | CTD | |
| G | PLD1 | phospholipase D1, phosphatidylcholine-specific |
|
decreases expression | ISO | 3 | 171,318,195 | 171,528,284 | RGD:6480464 | CTD | |
| G | PLEKHA1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
|
increases expression | ISO | 10 | 124,134,094 | 124,191,871 | RGD:6480464 | CTD | |
| G | PLIN2 | perilipin 2 |
|
increases expression | ISO | 9 | 19,115,759 | 19,127,604 | RGD:6480464 | CTD | |
| G | PLIN2 | perilipin 2 |
|
increases expression | ISO | 9 | 19,115,759 | 19,127,604 | RGD:6480464 | CTD | |
| G | PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
|
increases expression | ISO | 3 | 145,787,227 | 145,879,282 | RGD:6480464 | CTD | |
| G | PLSCR1 | phospholipid scramblase 1 |
|
affects expression | ISO | 3 | 146,232,967 | 146,262,628 | RGD:6480464 | CTD | |
| G | PLTP | phospholipid transfer protein |
|
increases expression | ISO | 20 | 44,527,259 | 44,541,003 | RGD:6480464 | CTD | |
| G | PMVK | phosphomevalonate kinase |
|
multiple interactions | ISO | 1 | 154,897,208 | 154,909,484 | RGD:6480464 | CTD | |
| G | PMVK | phosphomevalonate kinase |
|
increases expression | ISO | 1 | 154,897,208 | 154,909,484 | RGD:6480464 | CTD | |
| G | PNRC1 | proline-rich nuclear receptor coactivator 1 |
|
decreases expression | ISO | 6 | 89,790,429 | 89,794,879 | RGD:6480464 | CTD | |
| G | POLR1B | polymerase (RNA) I polypeptide B, 128kDa |
|
increases expression | ISO | 2 | 113,299,492 | 113,334,727 | RGD:6480464 | CTD | |
| G | POLR3A | polymerase (RNA) III (DNA directed) polypeptide A, 155kDa |
|
increases expression | ISO | 10 | 79,734,907 | 79,789,298 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
decreases expression | ISO | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
decreases expression | ISO | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON1 | paraoxonase 1 |
|
multiple interactions | ISO | 7 | 94,927,669 | 94,953,884 | RGD:6480464 | CTD | |
| G | PON2 | paraoxonase 2 |
|
multiple interactions | ISO | 7 | 95,034,174 | 95,064,384 | RGD:6480464 | CTD | |
| G | PON2 | paraoxonase 2 |
|
decreases expression | ISO | 7 | 95,034,174 | 95,064,384 | RGD:6480464 | CTD | |
| G | POR | P450 (cytochrome) oxidoreductase |
|
affects expression | ISO | 7 | 75,544,420 | 75,616,173 | RGD:6480464 | CTD | |
| G | POR | P450 (cytochrome) oxidoreductase |
|
increases expression | ISO | 7 | 75,544,420 | 75,616,173 | RGD:6480464 | CTD | |
| G | POR | P450 (cytochrome) oxidoreductase |
|
multiple interactions | ISO | 7 | 75,544,420 | 75,616,173 | RGD:6480464 | CTD | |
| G | POR | P450 (cytochrome) oxidoreductase |
|
increases expression | ISO | 7 | 75,544,420 | 75,616,173 | RGD:6480464 | CTD | |
| G | PPA2 | pyrophosphatase (inorganic) 2 |
|
decreases expression | ISO | 4 | 106,290,234 | 106,395,227 | RGD:6480464 | CTD | |
| G | PPAP2A | phosphatidic acid phosphatase type 2A |
|
increases expression | ISO | 5 | 54,720,682 | 54,830,873 | RGD:6480464 | CTD | |
| G | PPAP2B | phosphatidic acid phosphatase type 2B |
|
decreases expression | ISO | 1 | 56,960,419 | 57,045,257 | RGD:6480464 | CTD | |
| G | PPAP2C | phosphatidic acid phosphatase type 2C |
|
increases expression | ISO | 19 | 281,043 | 291,435 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | EXP | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases activity | EXP | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | EXP | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | EXP | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
decreases expression | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases activity | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases response to substance | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases response to substance | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
multiple interactions | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARA | peroxisome proliferator-activated receptor alpha |
|
increases activity | ISO | 22 | 46,546,499 | 46,639,653 | RGD:6480464 | CTD | |
| G | PPARD | peroxisome proliferator-activated receptor delta |
|
increases activity | ISO | 6 | 35,310,335 | 35,395,968 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | EXP | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
increases expression | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARG | peroxisome proliferator-activated receptor gamma |
|
multiple interactions | ISO | 3 | 12,329,349 | 12,475,855 | RGD:6480464 | CTD | |
| G | PPARGC1B | peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
|
increases expression | ISO | 5 | 149,109,815 | 149,234,585 | RGD:6480464 | CTD | |
| G | PPIL3 | peptidylprolyl isomerase (cyclophilin)-like 3 |
|
affects expression | ISO | 2 | 201,735,679 | 201,753,849 | RGD:6480464 | CTD | |
| G | PPIL3 | peptidylprolyl isomerase (cyclophilin)-like 3 |
|
increases expression | ISO | 2 | 201,735,679 | 201,753,849 | RGD:6480464 | CTD | |
| G | PPP1R10 | protein phosphatase 1, regulatory subunit 10 |
|
increases expression | ISO | 6 | 30,568,177 | 30,585,084 | RGD:6480464 | CTD | |
| G | PPP1R14A | protein phosphatase 1, regulatory (inhibitor) subunit 14A |
|
decreases expression | ISO | 19 | 38,741,877 | 38,747,231 | RGD:6480464 | CTD | |
| G | PPP1R15A | protein phosphatase 1, regulatory subunit 15A |
|
increases expression | ISO | 19 | 49,375,649 | 49,379,319 | RGD:6480464 | CTD | |
| G | PPP1R1A | protein phosphatase 1, regulatory (inhibitor) subunit 1A |
|
affects expression | ISO | 12 | 54,973,024 | 54,982,443 | RGD:6480464 | CTD | |
| G | PPP1R3B | protein phosphatase 1, regulatory subunit 3B |
|
decreases expression | ISO | 8 | 8,993,764 | 9,009,152 | RGD:6480464 | CTD | |
| G | PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha |
|
decreases expression | ISO | 1 | 212,458,879 | 212,535,205 | RGD:6480464 | CTD | |
| G | PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha |
|
affects expression | ISO | 1 | 212,458,879 | 212,535,205 | RGD:6480464 | CTD | |
| G | PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit |
|
decreases expression | ISO | 12 | 120,105,761 | 120,119,429 | RGD:6480464 | CTD | |
| G | PSMB5 | proteasome (prosome, macropain) subunit, beta type, 5 |
|
affects expression | ISO | 14 | 23,495,060 | 23,504,429 | RGD:6480464 | CTD | |
| G | PSMB5 | proteasome (prosome, macropain) subunit, beta type, 5 |
|
increases expression | ISO | 14 | 23,495,060 | 23,504,429 | RGD:6480464 | CTD | |
| G | PSMB6 | proteasome (prosome, macropain) subunit, beta type, 6 |
|
affects expression | ISO | 17 | 4,699,439 | 4,701,798 | RGD:6480464 | CTD | |
| G | PSMB6 | proteasome (prosome, macropain) subunit, beta type, 6 |
|
increases expression | ISO | 17 | 4,699,439 | 4,701,798 | RGD:6480464 | CTD | |
| G | PSMB6 | proteasome (prosome, macropain) subunit, beta type, 6 |
|
multiple interactions | ISO | 17 | 4,699,439 | 4,701,798 | RGD:6480464 | CTD | |
| G | PSMB7 | proteasome (prosome, macropain) subunit, beta type, 7 |
|
affects expression | ISO | 9 | 127,115,744 | 127,177,752 | RGD:6480464 | CTD | |
| G | PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 |
|
multiple interactions | ISO | 6 | 32,808,494 | 32,812,712 | RGD:6480464 | CTD | |
| G | PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 |
|
decreases expression | ISO | 6 | 32,808,494 | 32,812,712 | RGD:6480464 | CTD | |
| G | PSMC1 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
affects expression | ISO | 14 | 90,722,894 | 90,738,966 | RGD:6480464 | CTD | |
| G | PSMC1 | proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
increases expression | ISO | 14 | 90,722,894 | 90,738,966 | RGD:6480464 | CTD | |
| G | PSMC2 | proteasome (prosome, macropain) 26S subunit, ATPase, 2 |
|
increases expression | ISO | 7 | 102,987,971 | 103,009,842 | RGD:6480464 | CTD | |
| G | PSMC4 | proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
increases expression | ISO | 19 | 40,476,912 | 40,487,671 | RGD:6480464 | CTD | |
| G | PSMC5 | proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression | ISO | 17 | 61,904,770 | 61,909,387 | RGD:6480464 | CTD | |
| G | PSMC6 | proteasome (prosome, macropain) 26S subunit, ATPase, 6 |
|
affects expression | ISO | 14 | 53,173,896 | 53,194,716 | RGD:6480464 | CTD | |
| G | PSMD1 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
affects expression | ISO | 2 | 231,921,578 | 232,037,541 | RGD:6480464 | CTD | |
| G | PSMD11 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
|
affects expression | ISO | 17 | 30,771,481 | 30,810,337 | RGD:6480464 | CTD | |
| G | PSMD12 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 |
|
affects expression | ISO | 17 | 65,336,619 | 65,362,721 | RGD:6480464 | CTD | |
| G | PSMD13 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 |
|
affects expression | ISO | 11 | 236,808 | 252,984 | RGD:6480464 | CTD | |
| G | PSMD13 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 |
|
increases expression | ISO | 11 | 236,808 | 252,984 | RGD:6480464 | CTD | |
| G | PSMD14 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
affects expression | ISO | 2 | 162,164,786 | 162,268,228 | RGD:6480464 | CTD | |
| G | PSMD2 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 |
|
affects expression | ISO | 3 | 184,017,022 | 184,026,840 | RGD:6480464 | CTD | |
| G | PSMD3 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 |
|
affects expression | ISO | 17 | 38,137,021 | 38,154,213 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression | ISO | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
increases expression | ISO | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
multiple interactions | ISO | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD4 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
increases expression | ISO | 1 | 151,227,197 | 151,239,955 | RGD:6480464 | CTD | |
| G | PSMD6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
affects expression | ISO | 3 | 63,996,231 | 64,009,120 | RGD:6480464 | CTD | |
| G | PSMD7 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 |
|
affects expression | ISO | 16 | 74,330,673 | 74,340,186 | RGD:6480464 | CTD | |
| G | PSMD8 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
|
affects expression | ISO | 19 | 38,865,190 | 38,874,464 | RGD:6480464 | CTD | |
| G | PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
|
affects expression | ISO | 14 | 24,605,378 | 24,608,176 | RGD:6480464 | CTD | |
| G | PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
|
decreases expression | ISO | 9 | 125,132,809 | 125,157,982 | RGD:6480464 | CTD | |
| G | PTH1R | parathyroid hormone 1 receptor |
|
decreases expression | ISO | 3 | 46,919,236 | 46,945,289 | RGD:6480464 | CTD | |
| G | PTMS | parathymosin |
|
decreases expression | ISO | 12 | 6,875,541 | 6,880,118 | RGD:6480464 | CTD | |
| G | PTN | pleiotrophin |
|
decreases expression | ISO | 7 | 136,912,088 | 137,028,546 | RGD:6480464 | CTD | |
| G | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 |
|
increases expression | ISO | 6 | 64,281,920 | 64,293,489 | RGD:6480464 | CTD | |
| G | PTPN21 | protein tyrosine phosphatase, non-receptor type 21 |
|
increases expression | ISO | 14 | 88,932,122 | 89,021,123 | RGD:6480464 | CTD | |
| G | PTPRD | protein tyrosine phosphatase, receptor type, D |
|
affects expression | ISO | 9 | 8,314,246 | 10,612,723 | RGD:6480464 | CTD | |
| G | PTPRD | protein tyrosine phosphatase, receptor type, D |
|
decreases expression | ISO | 9 | 8,314,246 | 10,612,723 | RGD:6480464 | CTD | |
| G | PTPRF | protein tyrosine phosphatase, receptor type, F |
|
affects expression | ISO | 1 | 43,996,547 | 44,089,343 | RGD:6480464 | CTD | |
| G | PTPRF | protein tyrosine phosphatase, receptor type, F |
|
decreases expression | ISO | 1 | 43,996,547 | 44,089,343 | RGD:6480464 | CTD | |
| G | PTPRM | protein tyrosine phosphatase, receptor type, M |
|
decreases expression | ISO | 18 | 7,567,314 | 8,406,859 | RGD:6480464 | CTD | |
| G | PVR | poliovirus receptor |
|
increases expression | ISO | 19 | 45,147,098 | 45,169,429 | RGD:6480464 | CTD | |
| G | PXMP4 | peroxisomal membrane protein 4, 24kDa |
|
multiple interactions | ISO | 20 | 32,290,550 | 32,308,136 | RGD:6480464 | CTD | |
| G | PXMP4 | peroxisomal membrane protein 4, 24kDa |
|
increases expression | ISO | 20 | 32,290,550 | 32,308,136 | RGD:6480464 | CTD | |
| G | PXN | paxillin |
|
decreases expression | ISO | 12 | 120,648,242 | 120,703,574 | RGD:6480464 | CTD | |
| G | PYGL | phosphorylase, glycogen, liver |
|
decreases expression | ISO | 14 | 51,371,935 | 51,411,248 | RGD:6480464 | CTD | |
| G | PZP | pregnancy-zone protein |
|
decreases expression | ISO | 12 | 9,301,436 | 9,360,966 | RGD:6480464 | CTD | |
| G | QSER1 | glutamine and serine rich 1 |
|
increases expression | ISO | 11 | 32,914,792 | 33,001,816 | RGD:6480464 | CTD | |
| G | RAB38 | RAB38, member RAS oncogene family |
|
decreases expression | ISO | 11 | 87,846,415 | 87,908,635 | RGD:6480464 | CTD | |
| G | RAB5A | RAB5A, member RAS oncogene family |
|
increases expression | ISO | 3 | 19,988,572 | 20,026,667 | RGD:6480464 | CTD | |
| G | RAB5A | RAB5A, member RAS oncogene family |
|
increases expression | ISO | 3 | 19,988,572 | 20,026,667 | RGD:6480464 | CTD | |
| G | RAB5B | RAB5B, member RAS oncogene family |
|
decreases expression | ISO | 12 | 56,367,697 | 56,390,467 | RGD:6480464 | CTD | |
| G | RAB5B | RAB5B, member RAS oncogene family |
|
decreases expression | ISO | 12 | 56,367,697 | 56,390,467 | RGD:6480464 | CTD | |
| G | RAB6A | RAB6A, member RAS oncogene family |
|
increases expression | ISO | 11 | 73,386,683 | 73,472,201 | RGD:6480464 | CTD | |
| G | RABGGTB | Rab geranylgeranyltransferase, beta subunit |
|
increases expression | ISO | 1 | 76,251,886 | 76,260,764 | RGD:6480464 | CTD | |
| G | RARA | retinoic acid receptor, alpha |
|
decreases expression | ISO | 17 | 38,465,423 | 38,513,895 | RGD:6480464 | CTD | |
| G | RBL2 | retinoblastoma-like 2 (p130) |
|
decreases expression | ISO | 16 | 53,468,351 | 53,525,560 | RGD:6480464 | CTD | |
| G | RBP1 | retinol binding protein 1, cellular |
|
decreases expression | ISO | 3 | 139,236,276 | 139,258,671 | RGD:6480464 | CTD | |
| G | RBP2 | retinol binding protein 2, cellular |
|
decreases expression | ISO | 3 | 139,171,726 | 139,195,352 | RGD:6480464 | CTD | |
| G | RCAN2 | regulator of calcineurin 2 |
|
affects expression | ISO | 6 | 46,188,467 | 46,459,804 | RGD:6480464 | CTD | |
| G | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) |
|
increases expression | ISO | 14 | 68,143,517 | 68,162,510 | RGD:6480464 | CTD | |
| G | RDH5 | retinol dehydrogenase 5 (11-cis/9-cis) |
|
affects expression | ISO | 12 | 56,114,151 | 56,118,526 | RGD:6480464 | CTD | |
| G | RDH5 | retinol dehydrogenase 5 (11-cis/9-cis) |
|
decreases expression | ISO | 12 | 56,114,151 | 56,118,526 | RGD:6480464 | CTD | |
| G | RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | EXP | 11 | 65,421,067 | 65,430,443 | RGD:6480464 | CTD | |
| G | RESP18 | regulated endocrine-specific protein 18 |
|
increases expression | ISO | 2 | 220,192,131 | 220,197,899 | RGD:6480464 | CTD | |
| G | RFC1 | replication factor C (activator 1) 1, 145kDa |
|
decreases expression | ISO | 4 | 39,289,069 | 39,368,001 | RGD:6480464 | CTD | |
| G | RGN | regucalcin (senescence marker protein-30) |
|
decreases expression | ISO | X | 46,937,775 | 46,952,712 | RGD:6480464 | CTD | |
| G | RGS3 | regulator of G-protein signaling 3 |
|
decreases expression | ISO | 9 | 116,207,011 | 116,360,018 | RGD:6480464 | CTD | |
| G | RGS8 | regulator of G-protein signaling 8 |
|
decreases expression | ISO | 1 | 182,615,792 | 182,642,067 | RGD:6480464 | CTD | |
| G | RNASE4 | ribonuclease, RNase A family, 4 |
|
decreases expression | ISO | 14 | 21,152,372 | 21,168,758 | RGD:6480464 | CTD | |
| G | RNMT | RNA (guanine-7-) methyltransferase |
|
increases expression | ISO | 18 | 13,726,704 | 13,764,554 | RGD:6480464 | CTD | |
| G | ROM1 | retinal outer segment membrane protein 1 |
|
increases expression | ISO | 11 | 62,380,213 | 62,382,592 | RGD:6480464 | CTD | |
| G | RPH3AL | rabphilin 3A-like (without C2 domains) |
|
increases expression | ISO | 17 | 62,180 | 202,633 | RGD:6480464 | CTD | |
| G | RPIA | ribose 5-phosphate isomerase A |
|
affects expression | ISO | 2 | 88,991,176 | 89,050,452 | RGD:6480464 | CTD | |
| G | RPL10A | ribosomal protein L10a |
|
increases expression | ISO | 6 | 35,436,178 | 35,438,558 | RGD:6480464 | CTD | |
| G | RPL15 | ribosomal protein L15 |
|
increases expression | ISO | 3 | 23,958,295 | 23,965,187 | RGD:6480464 | CTD | |
| G | RPL18A | ribosomal protein L18a |
|
increases expression | ISO | 19 | 17,970,687 | 17,974,133 | RGD:6480464 | CTD | |
| G | RPL3 | ribosomal protein L3 |
|
increases expression | ISO | 22 | 39,708,887 | 39,715,670 | RGD:6480464 | CTD | |
| G | RPL4 | ribosomal protein L4 |
|
increases expression | ISO | 15 | 66,791,653 | 66,797,193 | RGD:6480464 | CTD | |
| G | RPP21 | ribonuclease P/MRP 21kDa subunit |
|
decreases expression | ISO | 6 | 30,312,906 | 30,314,635 | RGD:6480464 | CTD | |
| G | RPS10 | ribosomal protein S10 |
|
increases expression | ISO | 6 | 34,385,231 | 34,393,902 | RGD:6480464 | CTD | |
| G | RPS10 | ribosomal protein S10 |
|
increases expression | ISO | 6 | 34,385,231 | 34,393,902 | RGD:6480464 | CTD | |
| G | RPS19 | ribosomal protein S19 |
|
increases expression | ISO | 19 | 42,363,988 | 42,375,484 | RGD:6480464 | CTD | |
| G | RPS5 | ribosomal protein S5 |
|
increases expression | ISO | 19 | 58,898,636 | 58,906,171 | RGD:6480464 | CTD | |
| G | RYR1 | ryanodine receptor 1 (skeletal) |
|
decreases expression | ISO | 19 | 38,924,340 | 39,078,204 | RGD:6480464 | CTD | |
| G | RYR1 | ryanodine receptor 1 (skeletal) |
|
decreases expression | ISO | 19 | 38,924,340 | 39,078,204 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
multiple interactions | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SAA2 | serum amyloid A2 |
|
increases expression | ISO | 11 | 18,259,780 | 18,270,221 | RGD:6480464 | CTD | |
| G | SEPT4 | septin 4 |
|
decreases expression | ISO | 17 | 56,597,611 | 56,618,179 | RGD:6480464 | CTD | |
| G | SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
decreases expression | ISO | 14 | 95,027,783 | 95,036,243 | RGD:6480464 | CTD | |
| G | SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
decreases expression | ISO | 17 | 1,646,130 | 1,658,559 | RGD:6480464 | CTD | |
| G | SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
affects expression | ISO | 11 | 57,365,027 | 57,382,326 | RGD:6480464 | CTD | |
| G | SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
|
decreases expression | ISO | 11 | 57,365,027 | 57,382,326 | RGD:6480464 | CTD | |
| G | SGK1 | serum/glucocorticoid regulated kinase 1 |
|
decreases expression | ISO | 6 | 134,490,384 | 134,639,196 | RGD:6480464 | CTD | |
| G | SGMS1 | sphingomyelin synthase 1 |
|
increases expression | ISO | 10 | 52,065,345 | 52,383,737 | RGD:6480464 | CTD | |
| G | SH3GL3 | SH3-domain GRB2-like 3 |
|
decreases expression | ISO | 15 | 84,116,091 | 84,287,495 | RGD:6480464 | CTD | |
| G | SLBP | stem-loop binding protein |
|
increases expression | ISO | 4 | 1,694,527 | 1,714,030 | RGD:6480464 | CTD | |
| G | SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 |
|
decreases expression | ISO | 6 | 25,783,125 | 25,832,287 | RGD:6480464 | CTD | |
| G | SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
affects expression | ISO | 5 | 36,606,457 | 36,688,436 | RGD:6480464 | CTD | |
| G | SLC22A11 | solute carrier family 22 (organic anion/urate transporter), member 11 |
|
multiple interactions | EXP | 11 | 64,323,098 | 64,338,999 | RGD:6480464 | CTD | |
| G | SLC22A11 | solute carrier family 22 (organic anion/urate transporter), member 11 |
|
increases import | EXP | 11 | 64,323,098 | 64,338,999 | RGD:6480464 | CTD | |
| G | SLC22A12 | solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions | EXP | 11 | 64,358,282 | 64,369,820 | RGD:6480464 | CTD | |
| G | SLC22A12 | solute carrier family 22 (organic anion/urate transporter), member 12 |
|
increases import | EXP | 11 | 64,358,282 | 64,369,820 | RGD:6480464 | CTD | |
| G | SLC22A5 | solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
increases expression | ISO | 5 | 131,705,401 | 131,731,306 | RGD:6480464 | CTD | |
| G | SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions | ISO | 11 | 62,744,069 | 62,752,495 | RGD:6480464 | CTD | |
| G | SLC22A6 | solute carrier family 22 (organic anion transporter), member 6 |
|
increases import | ISO | 11 | 62,744,069 | 62,752,495 | RGD:6480464 | CTD | |
| G | SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 |
|
affects transport | ISO | 6 | 43,265,998 | 43,273,276 | RGD:6480464 | CTD | |
| G | SLC22A8 | solute carrier family 22 (organic anion transporter), member 8 |
|
affects transport | ISO | 11 | 62,760,296 | 62,783,317 | RGD:6480464 | CTD | |
| G | SLC22A8 | solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions | ISO | 11 | 62,760,296 | 62,783,317 | RGD:6480464 | CTD | |
| G | SLC22A8 | solute carrier family 22 (organic anion transporter), member 8 |
|
increases import | ISO | 11 | 62,760,296 | 62,783,317 | RGD:6480464 | CTD | |
| G | SLC25A1 | solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 |
|
decreases expression | ISO | 22 | 19,163,088 | 19,166,338 | RGD:6480464 | CTD | |
| G | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
affects expression | ISO | 3 | 48,894,356 | 48,936,426 | RGD:6480464 | CTD | |
| G | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
multiple interactions | ISO | 3 | 48,894,356 | 48,936,426 | RGD:6480464 | CTD | |
| G | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
increases expression | ISO | 3 | 48,894,356 | 48,936,426 | RGD:6480464 | CTD | |
| G | SLC25A20 | solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
|
increases expression | ISO | 3 | 48,894,356 | 48,936,426 | RGD:6480464 | CTD | |
| G | SLC25A23 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
|
decreases expression | ISO | 19 | 6,440,075 | 6,459,781 | RGD:6480464 | CTD | |
| G | SLC25A30 | solute carrier family 25, member 30 |
|
increases expression | ISO | 13 | 45,967,451 | 45,992,516 | RGD:6480464 | CTD | |
| G | SLC27A1 | solute carrier family 27 (fatty acid transporter), member 1 |
|
multiple interactions | ISO | 19 | 17,581,300 | 17,616,977 | RGD:6480464 | CTD | |
| G | SLC27A1 | solute carrier family 27 (fatty acid transporter), member 1 |
|
increases expression | ISO | 19 | 17,581,300 | 17,616,977 | RGD:6480464 | CTD | |
| G | SLC27A2 | solute carrier family 27 (fatty acid transporter), member 2 |
|
affects expression | ISO | 15 | 50,474,393 | 50,528,589 | RGD:6480464 | CTD | |
| G | SLC27A2 | solute carrier family 27 (fatty acid transporter), member 2 |
|
increases expression | ISO | 15 | 50,474,393 | 50,528,589 | RGD:6480464 | CTD | |
| G | SLC27A2 | solute carrier family 27 (fatty acid transporter), member 2 |
|
multiple interactions | ISO | 15 | 50,474,393 | 50,528,589 | RGD:6480464 | CTD | |
| G | SLC27A3 | solute carrier family 27 (fatty acid transporter), member 3 |
|
affects expression | ISO | 1 | 153,747,768 | 153,752,633 | RGD:6480464 | CTD | |
| G | SLC27A4 | solute carrier family 27 (fatty acid transporter), member 4 |
|
increases expression | ISO | 9 | 131,102,839 | 131,123,749 | RGD:6480464 | CTD | |
| G | SLC27A4 | solute carrier family 27 (fatty acid transporter), member 4 |
|
multiple interactions | ISO | 9 | 131,102,839 | 131,123,749 | RGD:6480464 | CTD | |
| G | SLC27A5 | solute carrier family 27 (fatty acid transporter), member 5 |
|
decreases expression | ISO | 19 | 59,009,700 | 59,023,432 | RGD:6480464 | CTD | |
| G | SLC29A1 | solute carrier family 29 (nucleoside transporters), member 1 |
|
decreases expression | ISO | 6 | 44,187,242 | 44,201,888 | RGD:6480464 | CTD | |
| G | SLC35A1 | solute carrier family 35 (CMP-sialic acid transporter), member A1 |
|
decreases expression | ISO | 6 | 88,182,643 | 88,222,057 | RGD:6480464 | CTD | |
| G | SLC37A4 | solute carrier family 37 (glucose-6-phosphate transporter), member 4 |
|
decreases expression | ISO | 11 | 118,895,061 | 118,901,616 | RGD:6480464 | CTD | |
| G | SLC38A2 | solute carrier family 38, member 2 |
|
decreases expression | ISO | 12 | 46,751,971 | 46,766,645 | RGD:6480464 | CTD | |
| G | SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression | ISO | 11 | 62,623,484 | 62,656,355 | RGD:6480464 | CTD | |
| G | SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression | ISO | 2 | 190,425,316 | 190,445,537 | RGD:6480464 | CTD | |
| G | SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression | ISO | 2 | 190,425,316 | 190,445,537 | RGD:6480464 | CTD | |
| G | SLC41A2 | solute carrier family 41, member 2 |
|
decreases expression | ISO | 12 | 105,197,275 | 105,322,472 | RGD:6480464 | CTD | |
| G | SLC4A4 | solute carrier family 4, sodium bicarbonate cotransporter, member 4 |
|
increases expression | ISO | 4 | 72,053,003 | 72,437,804 | RGD:6480464 | CTD | |
| G | SLC6A6 | solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
decreases expression | ISO | 3 | 14,444,106 | 14,530,857 | RGD:6480464 | CTD | |
| G | SLC7A1 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
|
increases expression | ISO | 13 | 30,083,551 | 30,169,825 | RGD:6480464 | CTD | |
| G | SLC9A1 | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
|
decreases expression | ISO | 1 | 27,425,300 | 27,481,621 | RGD:6480464 | CTD | |
| G | SLCO1B3 | solute carrier organic anion transporter family, member 1B3 |
|
affects expression | ISO | 12 | 20,963,638 | 21,069,845 | RGD:6480464 | CTD | |
| G | SLCO1C1 | solute carrier organic anion transporter family, member 1C1 |
|
decreases expression | ISO | 12 | 20,848,289 | 20,906,320 | RGD:6480464 | CTD | |
| G | SLPI | secretory leukocyte peptidase inhibitor |
|
decreases expression | ISO | 20 | 43,880,879 | 43,883,206 | RGD:6480464 | CTD | |
| G | SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
|
affects expression | ISO | 17 | 38,783,972 | 38,804,103 | RGD:6480464 | CTD | |
| G | SMC3 | structural maintenance of chromosomes 3 |
|
decreases expression | ISO | 10 | 112,327,449 | 112,364,392 | RGD:6480464 | CTD | |
| G | SMN1 | survival of motor neuron 1, telomeric |
|
increases expression | ISO | 5 | 70,220,768 | 70,248,839 | RGD:6480464 | CTD | |
| G | SMYD5 | SMYD family member 5 |
|
increases expression | ISO | 2 | 73,441,366 | 73,454,355 | RGD:6480464 | CTD | |
| G | SMYD5 | SMYD family member 5 |
|
increases expression | ISO | 2 | 73,441,366 | 73,454,355 | RGD:6480464 | CTD | |
| G | SNN | stannin |
|
multiple interactions | ISO | 16 | 11,762,289 | 11,773,015 | RGD:6480464 | CTD | |
| G | SNN | stannin |
|
decreases expression | ISO | 16 | 11,762,289 | 11,773,015 | RGD:6480464 | CTD | |
| G | SNRPB2 | small nuclear ribonucleoprotein polypeptide B |
|
affects expression | ISO | 20 | 16,710,609 | 16,722,417 | RGD:6480464 | CTD | |
| G | SOAT1 | sterol O-acyltransferase 1 |
|
increases expression | ISO | 1 | 179,262,849 | 179,327,815 | RGD:6480464 | CTD | |
| G | SOCS2 | suppressor of cytokine signaling 2 |
|
decreases expression | ISO | 12 | 93,963,598 | 93,970,521 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
decreases expression | ISO | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SORBS1 | sorbin and SH3 domain containing 1 |
|
affects expression | ISO | 10 | 97,071,530 | 97,321,171 | RGD:6480464 | CTD | |
| G | SORBS2 | sorbin and SH3 domain containing 2 |
|
decreases expression | ISO | 4 | 186,506,598 | 186,877,870 | RGD:6480464 | CTD | |
| G | SORD | sorbitol dehydrogenase |
|
decreases expression | ISO | 15 | 45,315,302 | 45,367,287 | RGD:6480464 | CTD | |
| G | SPINK1 | serine peptidase inhibitor, Kazal type 1 |
|
increases expression | ISO | 5 | 147,204,143 | 147,211,260 | RGD:6480464 | CTD | |
| G | SPINT2 | serine peptidase inhibitor, Kunitz type, 2 |
|
decreases expression | ISO | 19 | 38,755,098 | 38,783,254 | RGD:6480464 | CTD | |
| G | SPINT2 | serine peptidase inhibitor, Kunitz type, 2 |
|
decreases expression | ISO | 19 | 38,755,098 | 38,783,254 | RGD:6480464 | CTD | |
| G | SPP2 | secreted phosphoprotein 2, 24kDa |
|
decreases expression | ISO | 2 | 234,959,346 | 234,985,776 | RGD:6480464 | CTD | |
| G | SQLE | squalene epoxidase |
|
increases expression | ISO | 8 | 126,010,720 | 126,034,525 | RGD:6480464 | CTD | |
| G | SRD5A1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression | ISO | 5 | 6,633,500 | 6,669,675 | RGD:6480464 | CTD | |
| G | SRD5A1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
decreases expression | ISO | 5 | 6,633,500 | 6,669,675 | RGD:6480464 | CTD | |
| G | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
multiple interactions | ISO | 2 | 31,749,656 | 31,806,040 | RGD:6480464 | CTD | |
| G | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
decreases expression | ISO | 2 | 31,749,656 | 31,806,040 | RGD:6480464 | CTD | |
| G | ST3GAL5 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
|
increases expression | ISO | 2 | 86,066,271 | 86,116,157 | RGD:6480464 | CTD | |
| G | ST6GAL1 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
decreases expression | ISO | 3 | 186,648,315 | 186,796,341 | RGD:6480464 | CTD | |
| G | ST6GALNAC3 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
|
decreases expression | ISO | 1 | 76,540,389 | 77,096,669 | RGD:6480464 | CTD | |
| G | STAR | steroidogenic acute regulatory protein |
|
decreases expression | ISO | 8 | 38,000,218 | 38,008,600 | RGD:6480464 | CTD | |
| G | STK10 | serine/threonine kinase 10 |
|
increases expression | ISO | 5 | 171,469,074 | 171,615,346 | RGD:6480464 | CTD | |
| G | SULT1C3 | sulfotransferase family, cytosolic, 1C, member 3 |
|
decreases expression | ISO | 2 | 108,863,651 | 108,881,807 | RGD:6480464 | CTD | |
| G | SVIL | supervillin |
|
decreases expression | ISO | 10 | 29,746,277 | 30,024,730 | RGD:6480464 | CTD | |
| G | TMEM14C | transmembrane protein 14C |
|
increases expression | ISO | 6 | 10,723,148 | 10,731,362 | RGD:6480464 | CTD | |
| G | TPM3 | tropomyosin 3 |
|
decreases expression | ISO | 1 | 154,127,780 | 154,164,609 | RGD:6480464 | CTD | |
| G | TRMT6 | tRNA methyltransferase 6 homolog (S. cerevisiae) |
|
increases expression | ISO | 20 | 5,918,486 | 5,931,173 | RGD:6480464 | CTD | |
| G | UBALD1 | UBA-like domain containing 1 |
|
increases expression | ISO | 16 | 4,658,884 | 4,664,927 | RGD:6480464 | CTD | |
| G | UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 |
|
affects expression | ISO | 4 | 69,512,315 | 69,536,494 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
decreases expression | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
multiple interactions | ISO | 4 | 69,402,902 | 69,434,245 | RGD:6480464 | CTD | |
| G | UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 |
|
decreases expression | ISO | 4 | 70,146,217 | 70,160,768 | RGD:6480464 | CTD | |
| G | UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 |
|
affects expression | ISO | 4 | 70,146,217 | 70,160,768 | RGD:6480464 | CTD | |
| G | UNC5B | unc-5 homolog B (C. elegans) |
|
increases expression | ISO | 10 | 72,972,292 | 73,062,635 | RGD:6480464 | CTD | |
| G | UPB1 | ureidopropionase, beta |
|
decreases expression | ISO | 22 | 24,891,251 | 24,922,553 | RGD:6480464 | CTD | |
| G | UROC1 | urocanate hydratase 1 |
|
affects expression | ISO | 3 | 126,200,008 | 126,236,616 | RGD:6480464 | CTD | |
| G | VCP | valosin containing protein |
|
affects expression | ISO | 9 | 35,056,065 | 35,072,739 | RGD:6480464 | CTD | |
| G | VGLL3 | vestigial like 3 (Drosophila) |
|
affects expression | ISO | 3 | 86,987,123 | 87,040,257 | RGD:6480464 | CTD | |
| G | VHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
increases expression | ISO | 3 | 10,183,319 | 10,195,354 | RGD:6480464 | CTD | |
| G | VLDLR | very low density lipoprotein receptor |
|
increases expression | ISO | 9 | 2,621,793 | 2,654,485 | RGD:6480464 | CTD | |
| G | VLDLR | very low density lipoprotein receptor |
|
increases expression | ISO | 9 | 2,621,793 | 2,654,485 | RGD:6480464 | CTD | |
| G | VSNL1 | visinin-like 1 |
|
affects expression | ISO | 2 | 17,721,807 | 17,837,706 | RGD:6480464 | CTD | |
| G | VTN | vitronectin |
|
decreases expression | ISO | 17 | 26,694,298 | 26,697,373 | RGD:6480464 | CTD | |
| G | VWF | von Willebrand factor |
|
affects expression | ISO | 12 | 6,058,040 | 6,233,836 | RGD:6480464 | CTD | |
| G | WEE1 | WEE1 homolog (S. pombe) |
|
increases expression | ISO | 11 | 9,595,228 | 9,611,314 | RGD:6480464 | CTD | |
| G | WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 |
|
affects expression | ISO | 8 | 38,132,560 | 38,239,790 | RGD:6480464 | CTD | |
| G | WISP2 | WNT1 inducible signaling pathway protein 2 |
|
affects expression | ISO | 20 | 43,343,885 | 43,356,452 | RGD:6480464 | CTD | |
| G | XDH | xanthine dehydrogenase |
|
decreases activity | ISO | 2 | 31,557,188 | 31,637,611 | RGD:6480464 | CTD | |
| G | XDH | xanthine dehydrogenase |
|
decreases expression | ISO | 2 | 31,557,188 | 31,637,611 | RGD:6480464 | CTD | |
| G | XPO7 | exportin 7 |
|
decreases expression | ISO | 8 | 21,777,180 | 21,864,096 | RGD:6480464 | CTD | |
| G | XPO7 | exportin 7 |
|
decreases expression | ISO | 8 | 21,777,180 | 21,864,096 | RGD:6480464 | CTD | |
| G | YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
increases expression | ISO | 7 | 75,956,108 | 75,988,342 | RGD:6480464 | CTD | |
| G | ZEB2 | zinc finger E-box binding homeobox 2 |
|
affects expression | ISO | 2 | 145,141,942 | 145,277,958 | RGD:6480464 | CTD | |
| G | ZNF354A | zinc finger protein 354A |
|
increases expression | ISO | 5 | 178,138,522 | 178,157,703 | RGD:6480464 | CTD | |
| G | ZNF519 | zinc finger protein 519 |
|
decreases expression | ISO | 18 | 14,075,989 | 14,132,489 | RGD:6480464 | CTD | |
| G | ZNF622 | zinc finger protein 622 |
|
increases expression | ISO | 5 | 16,451,628 | 16,465,894 | RGD:6480464 | CTD | |
Term paths to the root
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term